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ABSTRACT 
Endurance exercise improves health partly though improvements in skeletal 
muscle function. Mitochondrial biogenesis is one of the mechanisms that 
underpin the positive health benefits of endurance exercise. Endurance-
exercise and energy sensitive pathways signal to promote transcriptional 
processes that initiate the adaptive response. Thus the aim of this thesis was to 
further understand the regulation of post-exercise signalling within skeletal 
muscle, with specific focus on the activation of energy-sensitive mitochondrial 
biogenic signalling pathways. It was demonstrated that muscle-specific 
knockout of p53 does not impair mitochondrial protein content or enzyme 
activity within mouse skeletal muscle. In human skeletal muscle, fasting and 
fasted-exercise augment CREBSer133 and AMPKThr172 phosphorylation, while the 
mRNA expression of PDK4 but not PPARGC1A is also increased in the fasted 
state. Finally, one week of nicotinamide riboside supplementation did not alter 
skeletal muscle mitochondrial respiration and whole-body substrate utilisation at 
rest or during endurance exercise, while SIRT1 and 3 activity and PPARGC1A 
mRNA expression at rest and following endurance-exercise are also unaffected 
by nicotinamide riboside supplementation. Overall, this thesis contributes novel 
data to the understanding of metabolism and skeletal muscle signalling 
following endurance exercise and how nutrition and endurance exercise could 
be integrated to optimise specific adaptations. 
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1.1 Abstract 
Endurance exercise is well established to improve health, with enhanced 
skeletal muscle mitochondrial biogenesis one of the mechanisms that underpins 
this adaptation. This process is regulated by complex signalling pathways that 
sense changes in metabolites, energy availability and contraction to initiate the 
transcriptional mitochondrial biogenic process. When repeated regularly, 
chronic activation of mitochondrial biogenesis results in a greater capacity for 
aerobic ATP synthesis, particularly from lipid sources, enhanced fatigue 
resistance and accelerated recovery in skeletal muscle. Importantly, the 
activation of these signalling pathways can be manipulated by exercise 
intensity, intermittency, duration and the nutritional environment that exercise is 
performed in. Thus developing strategies to enhance the activation of these 
signalling pathways holds therapeutic potential by augmenting mitochondrial 
biogenesis and oxidative capacity of skeletal muscle.  
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1.2 Endurance exercise for health  
Physical activity and endurance exercise training has long been known to 
improve health and wellbeing as well as improve prolonged athletic 
performance. Seminal work by Morris et al (223) described lower mortality rates 
in active bus conductors versus sedentary drivers. Subsequently, an enormous 
body of literature has demonstrated how physical activity, exercise or higher 
levels of cardiovascular fitness lower rates of or mortality from cardiovascular 
disease (28), type II diabetes (170), obesity (148), sarcopenia (89) and certain 
cancers (235), among other conditions.  
 
It is now beyond contention that maintaining adequate levels of physical activity 
throughout the lifespan is an important mediator of maintaining health. Many of 
the gross mechanisms have been elucidated (e.g. greater stroke volume, 
reduced blood pressure, reduced blood glucose concentration, greater muscle 
mass, increased skeletal muscle mitochondrial volume, etc.) and are described 
in section 1.2.1. However, many of the molecular mechanisms underpinning 
these adaptations are either not fully understood or methods of targeting these 
molecular pathways have not been completely established. It will therefore be 
the aim of this thesis to further understand the molecular mechanisms 
conferring skeletal muscle adaptations following endurance exercise, with a 
particular focus on targeting energy-sensing pathways to promote mitochondrial 
biogenesis. Mitochondria are the cellular site of aerobic ATP production, 
providing the majority of energy for cellular processes and as such are often 
referred to as the ‘powerhouses of the cell’. Within this thesis ‘mitochondrial 
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biogenesis’ is ultimately defined as an increase in capacity for oxidative 
phosphorylation and ATP production. Within this definition, ‘mitochondrial 
biogenesis’ encompasses both an increase in mitochondrial mass or volume 
per se and increases in respiratory efficiency of existing mitochondria. 
 
1.2.1 Adaptations to endurance exercise training  
Regular physical activity in the form of endurance training can substantially 
improve endurance capacity in a range of populations (38, 56, 88, 99, 224). 
This is achieved both by an increased maximal oxygen uptake (VO2max) and an 
ability to work at a given submaximal intensity with a smaller homeostatic 
disturbance (21). These outcomes are the result of the interaction between a 
series of physiological adaptations that ultimately result in an increased 
capacity for delivery and utilisation of oxygen and lipids for the synthesis of 
adenosine triphosphate (ATP) by oxidative phosphorylation in skeletal muscle. 
Furthermore, many of these adaptations have positive benefits not just in terms 
of endurance performance but also in general health. 
 
1.2.1.1 Cardiovascular adaptations to endurance exercise 
training 
Endurance exercise training results in an increase in VO2max principally by 
increases in cardiac output, via elevated stroke volume and reduced vascular 
systemic resistance (30, 153, 165), and elevated oxygen carrying capacity via 
increased red blood cell volume (30, 289). In addition, training-induced 
capillarisation of the musculature (144, 225) results in shorter diffusion 
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distances (286), which alongside possible increases in myoglobin concentration 
within working muscles (125) increases the oxygen extraction capacity of the 
musculature. Together, increased cardiac output and greater oxygen extraction 
by exercising muscles increases VO2max (307). 
 
1.2.1.2 Skeletal muscle adaptations to endurance exercise 
training 
While the cardiovascular system may limit maximal aerobic capacity, oxygen 
uptake at a given submaximal intensity is the same in the trained and untrained 
state (125). Therefore, exercise capacity at submaximal workloads is more 
closely related to adaptations in skeletal muscle (21), which demonstrates 
considerable plasticity when exposed to different functional demands. Following 
endurance training, the shift in whole-body substrate oxidation towards greater 
lipid oxidation (167) and reduced glycolysis (113) allows for a greater exercise 
intensity to be supported predominantly by aerobic energy production. This 
results in reduced lactate accumulation in blood and muscle (157, 285) and 
sparing of muscle glycogen stores (113), which play a pivotal role in the 
increased exercise capacity and performance following endurance training.  
 
Endurance exercise training results in a shift towards a more oxidative, fatigue-
resistant, phenotype of the trained muscle. An increased proportion of slow-
twitch type I, fast oxidative type IIa and hybrid fibres is apparent, with a 
reduction in rapidly fatiguing fast glycolytic type IIx and IIb fibres (9, 60, 301). 
This is caused by hypertrophy of type I and type IIa fibres (60) and a 
Nutrition and post-exercise energy-sensing in skeletal muscle 
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transformation of fibres to a slower phenotype, by an altered expression of 
myosin heavy chain isomers (262). The shift towards a slower muscular 
phenotype is of physiological importance to endurance performance given the 
close relationship between muscle fibre composition and both the oxygen cost 
of locomotion (66) and lactate threshold (146). Moreover, a shift in fibre-type 
distribution may affect glucose uptake and therefore insulin sensitivity because 
slower-oxidative fibres have a higher content of glucose transporter type 4 
(GLUT4) and mitochondrial metabolic proteins (69, 197), resulting in more 
effective removal of glucose from the blood and oxidation in mitochondria. 
 
1.2.1.3 Skeletal muscle mitochondrial adaptations to 
endurance exercise training 
Aerobic exercise promotes a large increase in mitochondrial mass, 
mitochondrial enzyme activity and oxidation efficiency (135, 138, 221, 236, 
308). Holloszy first demonstrated an increased mitochondrial enzyme activity in 
rats following progressive endurance training (135), a finding that has 
subsequently been replicated in numerous human studies (60, 99, 106, 138, 
191, 308). The activity of enzymes in the electron transport chain can increase 
up to two-fold in response to training (60, 135). Concentrations of cytochrome-c 
(Cyt-c) also increase by approximately two-fold, suggesting the increased 
enzyme activity is due to an increase in mitochondrial enzyme protein content 
(135). Crucially, in this study oxidative phosphorylation was tightly coupled, 
suggesting that the increase in electron transport capacity was associated with 
a proportional increase in the capacity for ATP production by oxidative 
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phosphorylation (135). Enzymes involved in the citric acid cycle (137), fatty acid 
oxidation (221) and ketone oxidation (353) also increase. However, 
mitochondrial enzymes do not respond in a uniform manner to endurance 
training. In response to the same exercise stimulus in rats, enzymes involved in 
the oxidation of fatty acids increase by approximately two-fold (221), whereas 
enzymes of the citric acid cycle only increase by up to 50% (137). Glycolytic 
enzymes remained unchanged, or even decrease in activity when expressed 
per milligram of mitochondrial protein content (136, 236). Therefore, regular 
endurance exercise results in an adaptive response to increase the capacity for 
ATP resynthesis by oxidative phosphorylation, especially from the oxidation of 
fatty acids, and in doing so reduces the reliance upon glycolysis.  
 
In an electron microscopy study, Gollnick and King (107) demonstrated an 
increased size, number and density of mitochondria following endurance 
exercise training in rats. Hoppeler et al (138) replicated this finding in a human 
cross-sectional study comparing the skeletal muscle of well-trained orienteers 
versus untrained controls, with further longitudinal studies confirming this 
training effect in humans (140, 323). Thus endurance exercise increases the 
absolute volume of the mitochondrial pool. 
 
In addition to increases in absolute mitochondrial volume, mitochondrial 
morphology and connectivity can also be modified by exercise (164). 
Mitochondria can exist as both a highly organised reticulum and as fragmented 
organelles, with mitochondria remodelled by fusion and fission events 
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dependent upon the metabolic state of the cell (186, 263, 370). Fragmented 
mitochondria have lower maximal rates of carbohydrate and fat oxidation (14, 
250), thus an alteration in the mitochondrial morphology, as well as overall 
content, may play a crucial role in the adaption to endurance exercise. There is 
growing evidence in support of endurance exercise as a stimulus for the 
proliferation of the mitochondrial reticulum (46, 77, 164, 242, 249). Endurance 
exercise training proliferates the mitochondrial reticulum in rat skeletal muscle 
(164) and increases the mRNA and protein expression of mitochondrial fusion 
proteins (164, 242). Acutely, Picard et al (249) have demonstrated that 
endurance exercise increases the number of electron dense contact sites 
between adjacent mitochondria in skeletal muscle of mice, hypothesised to 
increase electrical coupling between mitochondria (102). Furthermore, evidence 
of interconnecting mitochondria linked by matrix-filled membrane-bound bridges 
in the skeletal muscle of the exercising mice was apparent (249). However, 
while it is speculated that these processes may serve as pre-fusion events in 
mitochondria, no differences in mitochondrial fusion proteins or mitochondrial 
morphology were apparent between sedentary and exercising mice.  
 
Conversely to mitochondrial fusion, acute fission is also likely to occur following 
endurance exercise, which is required for removal of damaged and 
dysfunctional sections of mitochondria by mitophagy (332). Endurance exercise 
acutely activates the mitochondrial fission proteins fission 1 (Fis1) and dynamin-
related protein 1 (DRP1) in rodents and humans (77, 149, 150, 237). Critically, 
formation of highly oxidised isolated mitochondria can be visualised following 
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endurance exercise in mice (172). These mitochondria co-localise with the 
lysosome suggesting evidence of post-exercise mitophagy (172). However, 
there is currently no evidence of exercise-induced mitophagy in human skeletal 
muscle. Indeed, the expression of the mitophagy markers BCL2-interacting 
protein 3 (BNIP3), PTEN-induced putative kinase 1 (PINK1), or parkin do not 
change after ultra-endurance treadmill running (149) or cycling at 70% VO2peak 
for 30 minutes (303) or 2 hours (292) in humans.  
 
In addition to morphological changes in the overall mitochondrial reticulum, 
endurance exercise training may also alter the internal morphology of 
mitochondria. The density of mitochondrial cristae could influence mitochondrial 
efficiency (i.e. greater respiratory rates per mitochondrial volume or content) by 
determining the surface area for electron transfer (61). In a cross-sectional 
study, Nielsen et al (226) demonstrated increased cristae density in skeletal 
muscle mitochondria from endurance-trained athletes compared to inactive 
controls. However, it must be noted that earlier studies have reported no 
difference in cristae density between training statuses (138). Furthermore, 
Nielsen et al (226) found no change in cristae density of previously sedentary 
individuals following 10-weeks of endurance exercise training, while 28-days of 
skeletal muscle electrical stimulation in cats does not alter cristae density (295). 
Thus elevated cristae density with endurance exercise training remains 
controversial and, given the short-term resistance to changes in cristae density, 
is unlikely to explain evidence of increased mitochondrial respiratory capacity 
without changes in mitochondrial volume following exercise training (32, 244). 
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Another potential explanation for increased efficiency of mitochondrial 
respiration following endurance training (32, 244) could come from formation of 
supercomplexes within the electron transport chain. Complexes of the electron 
transport chain can assemble together to form supercomplexes, thereby 
minimising diffusion distances, increasing respiratory efficiency and reducing 
reactive oxygen species production (97). Following 16-weeks of endurance 
exercise training in humans, the overall content of supercomplexes increased in 
skeletal muscle, with a particularly striking redistribution of complex III and 
complex IV into SC I+III2+IVn supercomplexes (114). Indeed, exercise efficiency 
at baseline and the change with training is related to the fraction of complex IV 
in supercomplexes, while the proportion of complex III in supercomplexes was 
related to fat oxidation during exercise (114). Furthermore, the absolute amount 
of supercomplexes as well as the proportion of complex III and complex IV in 
supercomplexes is related to mitochondrial respiratory capacity in skeletal 
muscle (114). Thus, formation of supercomplexes within skeletal muscle 
following endurance exercise training is likely related to increased respiratory 
efficiency during exercise. 
 
Ultimately, endurance exercise training results in an increased skeletal muscle 
mitochondrial function. However, it is unclear whether this is driven by 
increased mitochondrial content or efficiency. In most instances it is likely to be 
a combination of the two, with the predominance dependent on exercise 
intensity, duration and volume (110, 111, 212, 267).  
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1.3 Role of skeletal muscle mitochondria in health and disease 
Deficiencies in skeletal muscle mitochondria result in glycolytic phenotypes 
displaying reduced oxidative phosphorylation, increased lactate production and 
reduced lipid oxidation. Animals displaying impaired skeletal muscle 
mitochondrial function can exhibit reduced endurance capacity (281), muscle 
atrophy (268) and accelerated ageing (79). Furthermore, a reduction in 
mitochondrial content and capacity for fatty acid oxidation occurs concomitantly 
with the development of insulin resistance and is associated with the degree of 
insulin resistance in humans (160, 300). Thus reduced mitochondrial mass, 
function and oxidative capacity appears related to metabolic inflexibility and the 
development of chronic metabolic diseases.  
 
During ageing there appears to be a natural decline in mitochondrial content 
and capacity (298, 335), a finding that is mirrored in studies of muscular disuse 
(31). However, this is a partially reversible process mediated by nutrition and 
physical (in)activity (335). Thus, conversely, increases in mitochondrial function 
can result in greater oxidative capacity and increased rates of lipid oxidation 
(135, 221). Importantly, exercise-induced increases in lipid oxidation can reduce 
intramuscular lipid accumulation and improve insulin sensitivity (35). 
Furthermore, training-induced increases in lipid oxidation during exercise and, 
especially, non-exercise activity thermogenesis have the potential to increase 
energy expenditure at the same relative intensity (325), thus itself becoming 
protective of obesity and the associated health implications. Therefore, 
understanding the fundamental process of mitochondrial biogenesis, of which 
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endurance exercise is a potent stimulator, holds great promise as a therapeutic 
tool for preventing and treating chronic diseases. Section 1.4 will discuss the 
current knowledge of the mechanisms that lead from acute and chronic 
exercise stimuli to mitochondrial biogenesis in skeletal muscle. Thus, hopefully, 
exercise regimes can be developed to specifically target adaptations in 
mitochondrial mass, morphology and, crucially, function. 
 
1.4 Energy-sensing in skeletal muscle  
During exercise, specialised energy, nutrient and contractile ‘sensors’ detect the 
metabolic disturbance caused by the increased demand for energy and 
subsequent utilisation of stored fuels. These exercise responsive sensor-
proteins initiate intracellular signalling networks that ultimately converge on 
transcriptional co-activators and transcription factors (240) that upregulate the 
expression of mitochondrial genes. If repeated chronically, these molecular 
signals promote an increased mitochondrial biogenesis.  
 
1.4.1 Alterations in adenine nucleotide availability drive 
remodelling through AMP-activated protein kinase (AMPK).  
ATP turnover is directly proportional to the work rate of skeletal muscle during 
sustained submaximal exercise (12). However, despite large increases in 
demand for energy during exercise, ATP concentration is tightly regulated 
within skeletal muscle (17, 40, 127, 128). For example, muscle ATP 
concentration only decreases by ~10-15% during prolonged (~100 min) or high-
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intensity (to failure) leg extensor exercise in humans (127, 128). Instead, it is 
metabolites of ATP (e.g. adenosine diphosphate (ADP) and adenosine 
monophosphate (AMP)) that undergo changes in cellular concentration, albeit 
within narrow ranges. To simplify somewhat, the reversible ATP reaction (2ADP 
↔ ATP + AMP) is maintained close to equilibrium under aerobic conditions 
(359). Therefore, a rise in the ADP:ATP ratio during exercise causes a shift 
towards ATP and AMP production in a manner related to the intensity of the 
muscle contraction (17, 52, 133). In addition to important feedback mechanisms 
in the control of glycolysis and respiration (68, 116), changes in free AMP and 
ADP can be sensed by AMP-activated protein kinase (AMPK). AMPK can then 
initiate intracellular signalling pathways that culminate in the activation of 
transcription factors and their co-activators involved in the regulation of 
mitochondrial biogenesis (Figure 1.1). 
AMPK is ubiquitously expressed and exists as heterotrimeric complexes, 
consisting of a catalytic α and regulatory β and γ sub-units (124). Within skeletal 
muscle, three AMPK heterotrimers are abundant (α1/β2/γ1, α2/β2/γ1 and 
α2/β2/γ3) (27). Furthermore, endurance exercise appears to preferentially 
activate the AMPKα2 isoform within human skeletal muscle (27, 95), particularly 
the α2/β2/γ3 complex (27, 329). Increases in the kinase activity of AMPK 
complexes occur upon allosteric activation by AMP at two Bateman domains 
contained within the γ-subunit (317). This allosteric activation results in a 
conformational change to the AMPK complex, aiding accessibility of upstream 
kinases to threonine 172 (230) and opposing dephosphorylation by protein 
phosphatases (288). Together these markedly increase AMPK enzymatic 
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activity (230). In addition to AMP, ADP binding may also alter cyclical AMPK 
phosphorylation patterns (231). The amplification of AMPK activity is therefore 
potently sensitive to both sustained increases in AMP and parallel fluctuations 
in the ADP:ATP ratio (315).  
 
In mammalian skeletal muscle, liver kinase B1 (LKB1) is generally considered 
the principal AMPKα2 kinase. Muscle-specific knockout (mKO) of LKB1 reduces 
AMPK and Acetyl-CoA carboxylase (ACC) (a classical downstream substrate of 
AMPK) phosphorylation at rest, while activation of AMPK α2 is diminished in 
response to in situ hind limb muscle contraction (280, 327). However, LKB1 
activity is unaltered by many AMPK activating stimuli, including exercise (279, 
311), suggesting it may be constitutively active and is unlikely to be an energy 
or nutrient sensor per se. Instead, it is likely that AMP and ADP-mediated 
conformational changes to AMPK allow additional LKB1-mediated 
phosphorylation, as well as opposing dephosphorylation at threonine 172 (231, 
288).  
 
AMPK can also be activated through a Ca2+-dependent phosphorylation via the 
calcium-calmodulin dependent kinase kinases (CAMKK) α/β (1, 126, 143, 151). 
Indeed, AMPK phosphorylation and activity is reduced in response to 
contraction in the presence of CAMKK inhibitors (1, 151). However, although 
CaMKKs may play a role in exercise-induced AMPK activation, it is unlikely to 
confer AMPK’s energy-sensing properties, as CAMKKs are likely sensitive to 
contractility rather than energy stress. 
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In addition to nucleotide fluctuations, muscle glycogen content can also regulate 
skeletal muscle AMPK activity (246). Elevating skeletal muscle glycogen 
content, via super-compensation, inhibits both contraction and pharmacological-
induced activation of AMPK (76, 355), even when AMP/ATP ratios are similar to 
a comparable low glycogen state (355). AMPK can bind glycogen via a 
glycogen-binding domain in its β-subunits (141, 204), regulated via an 
autophosphorylation site on threonine 148 in the glycogen binding domain that 
opposes glycogen binding (233, 234). The inhibition of binding and therefore 
release of AMPK from the glycogen particle may subsequently render AMPK 
more accessible for phosphorylation and activation. This idea is supported by 
reduced AMPK-glycogen binding and augmentation of AMPKThr172 
phosphorylation, AMPKα2 nuclear abundance and AMPK kinase activity when 
exercise is commenced with depleted glycogen (20, 171, 247, 316, 356, 365).  
 
AMPK activity is also sensitive to exercise intensity (52, 83, 95, 256). Cycling 
exercise at moderate (59 ± 1% VO2peak), and high (79 ± 1% VO2peak) but not low 
(40 ± 2% VO2peak) intensity is associated with increases in the AMP:ATP ratio 
(52), while glycogen utilization is greater in high (80% VO2peak) versus low (40% 
VO2peak) intensity cycling exercise (24). Concomitantly, AMPKα2 activity is 
increased sequentially from low to high exercise intensities (52, 83).  
 
A role for AMPK in skeletal muscle endurance capacity is supported by the 
observation that exercise capacity and adaptation to exercise training is 
dramatically reduced in AMPK β1/β2 mKO mice (229) and AMPK-α1/α2 mKO 
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mice (87). However, it should also be noted that impairments in mitochondrial 
adaptions in AMPK-α1/α2 mKO mice appeared to be more closely related to 
impaired exercise performance and, thus, reduced work achieved as opposed 
to reduced AMPK signalling (87). In support, when AMPK-α1/α2 mKO mice 
were matched with wild-type (WT) mice for training volume, the majority of 
chronic gene and protein responses were similar between genotypes (87). 
Recently, an inducible muscle-specific AMPK-α1/α2 KO mouse was developed 
that, due to the acute ablation of AMPK, do not display the mitochondrial 
dysfunction seen in all of the previously studied AMPK deficient models (130). 
This model therefore provides the best opportunity to date, to investigate the 
direct contribution of AMPK to exercise-induced signalling transduction and 
mitochondrial biogenesis. 
 
Mechanistically, AMPK can increase skeletal muscle mitochondrial biogenesis 
(199) through both direct and indirect processes. For example, chronic 
activation of AMPK with 5-aminoimidazole-4-carboxamide ribonucleoside 
(AICAR) enhances transcription of peroxisome proliferator-activated receptor 
(PPAR) gamma, PPARγ coactivator 1-alpha (PGC1α) and nuclear respiratory 
factor 1 (NRF1), with subsequent increases in mitochondrial biogenesis in 
rodent skeletal muscle (25, 178, 354). It appears as though this effect is reliant 
upon functional PGC1α, potentially through the direct phosphorylation of 
threonine 177 and serine 538 on PGC1α (147). However, although increases in 
AMPKα2 activity are associated with an exercise intensity dependent regulation 
of PGC1α mRNA abundance in human skeletal muscle (83), AMPK-mediated 
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phosphorylation of PGC1α has not been confirmed in vivo and so the relevance 
of this process for exercising skeletal muscle remains unknown (the role of 
PGC1α in mitochondrial biogenesis is further discussed in section 1.4.4.1). 
 
Whilst the direct phosphorylation of PGC1α by AMPK remains to be determined 
in skeletal muscle in vivo, there is clear evidence that AMPK regulates PGC1α 
transcription in exercising skeletal muscle through a histone deacetylase 5 
(HDAC5)/ myocyte enhancer factor 2 (MEF2) pathway (207). Exercise-induced 
nuclear translocation of AMPK (208, 247, 316) may lead to the phosphorylation 
of HDAC5 at serines 259 and 498, which inactivates HDAC5 and leads to 
HDAC5 nuclear export (257). This removes HDAC5-mediated inhibition of 
MEF2, allowing MEF2 to transcriptionally activate numerous genes involved in 
oxidative metabolism including PGC1α and GLUT4 gene transcription (8, 209).  
 
AMPK has also been identified as an upstream kinase of the transcription factor 
cyclic adenosine monophosphate (cAMP) response-element binding protein 
(CREB) (326). Typically phosphorylated by protein kinase A (PKA), a 
downstream substrate of cAMP (119), Thomson et al (326) demonstrated 
AMPK phosphorylation of CREB serine 133 in both rat liver and skeletal 
muscle. Additionally, AICAR induces phosphorylation of CREBSer133 in 
incubated epitrochlearis muscles (326). Furthermore, knock out (KO) of 
AMPKα2 results in decreased basal transcription of HKII and PGC1α, both 
genes containing cAMP response-element (CRE) promoters (155) (the role of 
CREB in mitochondrial biogenesis is discussed further in section 1.4.4.3). 
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AMPK activation also contributes to the activation of autophagy and mitophagy 
through phosphorylation of unc-51 like autophagy activating kinase 1 (ULK1) at 
multiple sites (serines 317, 467, 555, 637 and 777 and threonine 575) (84). 
Utilising electroporation of the mitophagy reporter construct MitoTimer in mouse 
skeletal muscle, Laker et al (172) have recently reported that exercise-induced 
ULK1 phosphorylation, lysosomal biogenesis and mitophagy are abolished in 
mice expressing a dominant-negative form of the AMPKα2-subunit (and thus 
lacking catalytic activity), while skeletal muscle ULK1 was also required for 
effective mitophagy (172). Together these data highlight the importance of the 
AMPK-ULK1 interaction for mitochondrial quality control following endurance 
exercise. 
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Figure 1.1 AMPK signalling pathway 
AMPK senses cellular energy flux via allosteric activation by AMP and by 
inactivating binding to glycogen. AMPKThr172 phosphorylation by upstream 
kinases increases AMPK catalytic activity. AMPK induces mitochondrial 
biogenesis principally via direct and indirect activation of PGC1α. Direct 
phosphorylation of PGC1α increases PGC1α transcriptional co-activation. 
Furthermore, phosphorylation of HDACs release repression of MEF2 and, 
alongside direct phosphorylation of CREB by AMPK, enhances expression of 
PGC1α and nuclear-encoded mitochondrial proteins. 
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1.4.2 Alterations in NAD+/NADH availability promote 
mitochondrial biogenesis through NAD+-dependent 
deacetylases 
Nicotinamide adenine dinucleotide (NAD+) and its reduced product NADH 
(NADH) are well characterised for their roles in energy metabolism. More 
recently, a role for NAD+ as a signalling moiety within skeletal muscle has 
emerged (139). During glycolysis and oxidative phosphorylation, substantial 
inter-conversion of NADH and NAD+ are required (309). These reducing 
equivalents participate in reduction-oxidation reactions, regulating metabolism 
both in the cytosol and mitochondria and are consumed as co-substrates for 
NAD+-dependent reactions involving sirtuins (SIRTs), poly (ADP-ribose (ADPR)) 
polymerases (PARPs) and cyclic ADPR synthases, producing nicotinamide 
(NAM) and ADPR (23, 192, 306).  
 
Continual synthesis or salvage of NAD+ is required to preserve cellular NAD+ 
concentrations. De novo synthesis occurs through a multistep process from 
tryptophan or via pathways from forms of vitamin B3; NAM, nicotinic acid (NA) 
or nicotinamide riboside (NR), collectively termed niacin (29). Each NAD+ 
precursor has it’s own cellular pathway for NAD+ synthesis (Figure 1.2). NA 
enters the Preiss-Handler pathway, relying on nicotinic acid 
phosphoribosyltransferase (NAPRT)-mediated conversion to nicotinic acid 
mononucleotide (NAMN) and nicotinic acid adenine dinucleotide (NAAD) by 
nicotinamide mononucleotide adenylyltransferases (NMNATs) prior to synthesis 
of NAD+ by NAD+ synthase 1 (NADSYN1). Via the salvage pathway, NAM and 
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NR are converted to nicotinamide mononucleotide (NMN) by nicotinamide 
phosphoribosyltransferase (NAMPT) and nicotinamide riboside kinases (NRKs), 
respectively, prior to synthesis of NAD+ by NMNATs (29). In addition, 
intracellular salvage of NAD+ can occur from NAM via the same pathway. NAM 
salvage can be prevented by nicotinamide N-methyltransferase (NNMT)-
mediated methylation to N1-methylnicotinamide (MeNAM) (29). Thus the 
efficiency of salvage of NAM versus methylation to MeNAM should regulate 
cellular NAD+ concentrations and, potentially, global metabolism (65, 168). 
 
Different tissues display different expression and reliance upon NAD+ 
synthesis/salvage pathways (91, 222). Within skeletal muscle, metabolites of 
the Preiss-Handler pathway and NADSYN1 activity are mostly undetectable, 
with NAD+ synthesis/salvage mediated predominantly via the salvage pathway 
(91, 222). NAD+ precursors relying upon the Preiss-Handler pathway (e.g. 
nicotinic acid riboside (NAR)) or de novo synthesis pathway (e.g. tryptophan) 
fail to increase myocyte NAD+ (91, 192), while robust increases are apparent 
with precursors mediated by the salvage pathway (e.g. NR, NAM and NMN) 
(91, 192). NAMPT is the rate-limiting enzyme in NAD+ salvage within skeletal 
muscle (65, 91, 92), while NRKs are required for exogenous NR- and NMN-
induced NAD+ accumulation albeit with redundancy between NRK1 and NRK2 
(91). Indeed, extracellular NMN is converted to NR outside of the myocyte 
before re-phosphorylation back to NMN and then NAD+ intracellularly (91, 192, 
265). 
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Figure 1.2 NAD+ synthesis and salvage pathways 
NAD+ is synthesised from tryptophan via de novo synthesis, from NA via the 
Preiss-Handler pathway or from NAM and NR via salvage pathways. NAD+ can 
be reduced to NADH or consumed as a substrate of SIRTs, PARPs and cyclic 
ADPR synthases forming NAM and ADPR. NAD+ can be re-synthesised from 
NAM via the salvage pathway or alternatively NAM can be methylated to form 
MeNAM, preventing NAD+ salvage. 
 
How NAD+/NADH concentrations are altered during exercise is still unclearly 
defined, primarily due to limitations in dynamic measurement approaches (see 
review (346)). In trained and untrained rats, low-intensity contractions increase 
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mitochondrial and cytosolic NAD+ and the NAD+/NADH ratio (82). Furthermore, 
elevations in the NAD+/NADH ratio occur across a range of contraction 
intensities (10-100% VO2max) in canine skeletal muscle (63). Conversely, a 
series of studies performed by Dr Kent Sahlin and colleagues demonstrated 
that exercise appears to have the opposite effect on the redox state of human 
skeletal muscle. Maximal cycling exercise to exhaustion and submaximal 
isometric contractions (two-thirds maximal voluntary contraction force) alter total 
NADH concentration ~140% above pre-exercise levels (129, 276) without 
significant changes in NAD+ concentration. In contrast, submaximal exercise at 
50% V O2max decreases total muscle NADH concentrations (158), while 
continuous exercise at 75% V O2max did not alter NADH levels (277). 
Fluctuations in the ratio of NAD+/NADH are also affected by exercise intensity, 
for example, NADH decreased while the cytosolic NAD+/NADH ratio was 
unaffected during exercise at 40% VO2max but at higher intensities, 75% and 
100% VO2max, NADH increased above pre-exercise values with no changes in 
NAD+ concentration (278). Thus it appears that high exercise intensities 
resulting in limited cellular oxygen availability are required to uncouple the 
stable inter-conversion between NAD+ and NADH.  
 
NAD+ has been identified as an obligatory co-substrate for sirtuin activity 
(Figure 1.3) (306). Gerhart-Hines and colleagues first demonstrated that 
increases in NAD+ increased PGC1α deacetylation in a SIRT1-dependent 
manner, an effect that was coincidental with increased mRNA expression of 
proteins involved in mitochondrial fatty acid oxidation (98). However, defining 
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the in vivo role of SIRT1 in mitochondrial biogenesis has been more 
problematic. For example, SIRT1 gene expression, protein content and 
deacetylase activity are poorly correlated with skeletal muscle oxidative 
capacity (48), whilst overall skeletal muscle and nuclear SIRT1 content 
decreases with exercise training and contraction in humans and rats (117, 118). 
However, nuclear SIRT1 enzymatic activity is more closely related to exercise 
and contraction induced mitochondrial biogenesis (117, 118). Furthermore, 
overexpression of SIRT1 in skeletal muscle results in mitochondrial biogenesis, 
in a manner that increases transcription of PGC1α and PGC1α target genes as 
well as PGC1α deacetylation (49). Together these data highlight the functional 
role of skeletal muscle SIRT1 in mitochondrial biogenesis. 
 
However, skeletal muscle SIRT1 is not required for exercise-induced 
mitochondrial biogenesis. Muscle-specific loss of SIRT1 deacetylase activity 
(SIRT1 mKO) does not impair the mitochondrial biogenic response to voluntary 
wheel running (VWR) in mice (214, 245). Furthermore, post-exercise PGC1α 
deacetylation and increases in PGC1α gene expression and nuclear protein 
content were preserved in SIRT1 mKO mice (245). This paradoxical 
deacetylation of PGC1α was attributed to a reduction in the interaction between 
PGC1α and the acetyltransferase general control of amino acid synthesis 5 
(GCN5) in SIRT1 mKO mice, which would lead to similar net deacetylation of 
PGC1α despite loss of SIRT1 function (245). It has been previously reported 
that GCN5 negatively regulates the PGC1α transcriptional pathway through 
acetylation in cultured hepatic cells (182). In a follow up to the discussed SIRT1 
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mKO study, Dent et al (75) produced a GCN5 mKO mouse and demonstrated 
that it does not enhance exercise-induced mitochondrial biogenesis, providing 
further evidence for the in vivo redundancy in exercise-induced PGC1α-related 
mitochondrial biogenesis. 
 
SIRT1 and AMPK activity are thought to be interdependent, following the 
discovery that AMPK activating stimuli in vitro and in vivo, including endurance 
exercise, fasting and AICAR treatment, results in an AMPK-dependent 
deacetylation of PGC1α and forkhead box protein O1 (FOXO1) (43, 45). 
Furthermore, SIRT1 is required for in vitro effects of AICAR-induced PGC1α 
deacetylation, PGC1α transcriptional activity and the associated induction of 
mitochondrial respiration (43). AMPK appears to regulate SIRT1 activity 
indirectly, through an elevation of cellular NAD+(43, 45), potentially driven by 
elevations in β-oxidation (43) or upregulated NAMPT expression (34, 45). 
Phosphorylation of PGC1α was also necessary for AICAR-induced SIRT1-
mediated PGC1α deacetylation independently of alterations in SIRT1 activity or 
NAD+ concentrations (43). This provides evidence that the interplay between 
phosphorylation and acetylation can determine substrate-specific activity. 
 
SIRT1 has also been suggested to regulate AMPK activity through 
deacetylation and activation of the upstream kinase LKB1 (173). However, the 
physiological relevance of this to exercise could be questioned, as LKB1 does 
not increase its activity in response to contraction (279). Indeed, Philp et al 
(245) have demonstrated that muscle-specific loss of SIRT1 deacetylase 
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activity does not impair endurance exercise induced AMPK phosphorylation and 
activation. Thus SIRT1 is not required for exercise-induced AMPK activation. 
 
Whilst the majority of sirtuin research in skeletal muscle has centred on SIRT1, 
the mitochondrially-localised SIRT3 is also of interest (294). SIRT3 is 
ubiquitously and differentially expressed in vivo, enriched in metabolically 
vigorous tissues such as the brain, heart, liver and skeletal muscle (195, 238). 
In contrast to SIRT1, SIRT3 protein levels are more abundant in slow-twitch 
(soleus), compared to fast-twitch (extensor digitorum longus and 
gastrocnemius) muscles, consistent with tissues with a higher mitochondrial 
content and oxidative potential (238). SIRT3 protein content increases following 
exercise training (33, 134, 174, 238), short-term fasting and long-term calorie 
restriction (238), and is down regulated in mouse models of insulin-resistance 
(152) and aged human muscle (174). This suggests that SIRT3 is a 
metabolically flexible protein that may regulate positive effects on mitochondrial 
oxidative capacity and whole-body metabolism. 
 
Analysis of acetylated substrates in WT and SIRT3 KO muscle identified 
proteins of complex I, complex III and the ATPase subunit of complex V are 
SIRT3-specific targets (152). Skeletal muscle specific SIRT3 gain of function 
has been reported to increase basal energy expenditure and improve 
endurance capacity, likely due to a phenotypic shift towards oxidative fibres in 
fast skeletal muscle (188). Beyond activation by NAD+, it has been suggested 
that AMPK may regulate SIRT3, as AICAR-mediated increases in SIRT3 and its 
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downstream substrate superoxide dismutase 2 (MnSOD) were lost in AMPK-α2 
kinase dead mice (33). Of interest, SIRT3 can also regulate AMPK activity, as 
KO of SIRT3 decreases AMPK and CREB phosphorylation and PGC1α 
expression in response to caloric restriction (238), whilst muscle-specific SIRT3 
gain of function mice display elevated AMPK phosphorylation and PPARδ 
expression (188). Potential mechanisms for this could be through the 
deacetylation and activation of LKB1 (252) or through alterations in ATP 
concentrations via interactions with energy modulating proteins (2, 120, 175, 
238). 
 
SIRT1 and SIRT3 also deacetylate and activate the transcription factors FOXO1 
and FOXO3 in skeletal muscle (26, 43, 45). FOXO1 increases the transcription 
of pyruvate dehydrogenase kinase 4 (PDK4), lipoprotein lipase (LPL) and 
increases the membrane localisation of fatty acid translocase (CD36), resulting 
in a shift towards fatty acid oxidation (22, 64, 96, 156). SIRT3-mediated FOXO3 
deacetylation increases FOXO3 binding to mitochondrial DNA (mtDNA) to 
activate mitochondrial transcription and increase mitochondrial respiration 
(243). Interestingly, AMPK can also positively regulate FOXO3 activity via 
phosphorylation (287) and may also mediate SIRT1 and SIRT3 deacetylation of 
FOXOs (43, 45, 243). During fasting and after exercise, FOXO1 is deacetylated 
in murine skeletal muscle (45). Furthermore, acute endurance exercise 
increases the expression of FOXO1 and its transcriptional target 
thrombospondin 1 (THBS1) (302). 
 
Nutrition and post-exercise energy-sensing in skeletal muscle 
  28 
Beyond the regulation of sirtuins, NAD+ can also modulate cellular metabolism 
through the PARP enzyme family (15, 16, 39, 59, 253, 291). PARylation is a 
post-translational modification in which active PARPs catalyse a reaction 
whereby NAD+ is cleaved to NAM and ADPR, the latter moiety covalently 
transferring an ADPR polymer to acceptor proteins (including PARP1 itself via 
auto-PARylation), building poly-ADPR (PAR) polymers (39, 291). As NAD+ 
consumers, PARPs are direct competitors with SIRT1, both of which are 
nuclear enzymes that require NAD+ for their catalytic activity (163, 174, 306). 
PARP1 induction in C2C12 cells leads to a rapid depletion in NAD+, and 
subsequent hyperacetylation of PGC1α, indicative of reduced SIRT1 activity 
(16). Further, in vitro inhibition of PARP2 via miR-149, increased NAD+ levels, 
enhanced SIRT1 activity and increased PGC1α transcriptional activity (219). 
Both PARP1 and PARP2 depletion results in higher SIRT1 activity in skeletal 
muscle in vivo, increasing mitochondrial content, improving glucose disposal, 
insulin sensitivity and protecting from high-fat diet induced obesity (15, 16, 253).  
 
Skeletal muscle contraction concomitantly elevates the activities of PARP1 and 
SIRT1 in mice (220). Furthermore, in support of PARP1-SIRT1 competition for 
cellular NAD+, PARP1 activity increased to a greater extent in aged skeletal 
muscle; reducing NAD+ concentrations, impairing PGC1α deacetylation and 
lowering the expression of mitochondrial biogenic genes, an effect abolished 
with PARP1 inhibition (220). In human skeletal muscle the regulation of PARPs 
is an emerging field. Cobley et al (59) corroborated the mouse data of 
Mohamed et al (220), demonstrating elevated PARP1 protein content in elderly 
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skeletal muscle. Furthermore, the effect of acute high-intensity interval exercise 
(5 x 2 minutes at 80% Wmax) on PARP1 content seems to differ with age and 
training status with PARP1 content increasing in young untrained males, whilst 
decreasing post-exercise in elderly participants (59). In young trained or 
recreationally active participants, PARP1 protein content does not change 
acutely following high-intensity (59) or concurrent exercise (304). However, 
PARP activity (i.e. PARylation) remains to be assessed in exercised human 
skeletal muscle. 
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Figure 1.3 NAD+-related signalling pathways 
Increases in cellular NAD+ concentration can activate SIRTs and PARPs. 
During exercise SIRT1 deacetylates and activates PGC1α and p53 to promote 
mitochondrial biogenesis. Activation of the mitochondrially-localised SIRT3 
deacetylates and activates multiple proteins of the electron transport chain, 
increasing respiratory efficiency. PARPs also consume NAD+ and as such 
oppose the activities of SIRTs and, thus, mitochondrial biogenesis. 
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1.4.3 Additional pathways 
1.4.3.1 CAMKII 
Recently, motor-neuron driven oscillations in cytoplasmic calcium have been 
identified as central molecular signals to remodel skeletal muscle during and in 
response to endurance exercise (53, 324, 361). Calmodulin (CaM)-dependent 
protein kinases (CaMKs) are sensitive to movements in cytosolic Ca2+ and 
become phosphorylated during exercise (Figure 1.4). In human skeletal muscle 
CaMKII is the predominant isoform and is activated in an intensity-dependent 
manner (270). Increased activity occurs concomitantly with increased 
autophosphorylation on threonine 286 (270), with autonomous CaMKII activity 
and threonine 286 phosphorylation highly correlated in exercised human 
skeletal muscle (271). CaMKII phosphorylation also appears to be sensitive to 
the elevated metabolic fluctuations apparent during intermittent versus 
continuous exercise (62). However, not all human acute endurance exercise 
studies detect changes in CaMKII phosphorylation (256). 
 
Mechanistically, CaMKII may contribute to exercise-induced mitochondrial 
biogenesis by indirectly regulating PGC1α transcription through phosphorylation 
of MEF2 and activating factor 2 (ATF2) either directly or mediated via 
phosphorylation and activation of p38 mitogen-activated protein kinase (p38 
MAPK) (206, 357, 360). These phosphorylation events promote MEF2 or ATF2 
assembly on the PGC1α promoter (on MEF2 and CRE binding sites, 
respectively), augmenting PGC1α transcription (7). ATF2 is required for CaMKII 
and p38 MAPK induced expression of PGC1α in response to contraction or 
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caffeine treatment (6, 7, 357), while mutation of the MEF2 and CRE (ATF2 
target) binding sites abolishes PGC1α promoter activity during contraction (6). 
Additionally, CaMKII and AMPK phosphorylation of HDACs induces nuclear 
export (193, 205, 206, 209, 210), indirectly increasing PGC1α transcription by 
reducing the ability of HDACs to repress MEF2 activity (6). In exercised human 
skeletal muscle, HDAC 4/5/7 and ATF2 phosphorylation display a similar time-
course and exercise intensity-dependency as CaMKII and AMPK, but not p38 
MAPK, phosphorylation (83). Indeed, discordance between CaMKII and p38 
MAPK regulation (83, 100) suggests additional decisive stimuli for p38 MAPK 
regulation (see section 1.4.3.2).  
 
It has also been proposed that CaMKII may phosphorylate and activate the 
transcription factor CREB, however this evidence mainly arises from studies 
from other tissues and cell lines (e.g. (296)). In human skeletal muscle, 
incompatibility between the time course of post-exercise CaMKIIThr286 and 
CREBSer133 phosphorylation (83) and a lack of correlation between endurance 
training altered CaMKII expression and CREB phosphorylation (269) suggests 
alternative regulation of CREB. Indeed, in smooth vascular muscle CaMKII 
inhibition has no effect on CREBSer133 phosphorylation, while CaMKII actually 
negatively regulates CREB activity through phosphorylation of the inhibitory 
serine 142 site (194). Nonetheless, the regulation of CREB activity by CaMKII in 
skeletal muscle remains debated. 
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1.4.3.2 p38 MAPK 
The MAPKs are a ubiquitously expressed family of kinases able to respond to a 
myriad of cellular stressors. p38 MAPK is able to translate these cellular 
stresses into a wide variety of adaptive responses including cell proliferation, 
differentiation and mitochondrial biogenesis (Figure 1.4) (7, 254, 363, 372). In 
exercising human skeletal muscle, p38 MAPK is phosphorylated and activated 
(19, 62, 83, 132, 347), independently of exercise intensity (83), and may 
mediate post-exercise mitochondrial biogenesis (7, 254). However, not all acute 
endurance exercise studies performed in humans detect changes in p38 MAPK 
phosphorylation (20, 256). 
 
The importance of p38 MAPK as a signalling moiety in skeletal muscle 
adaptation to endurance exercise was eloquently demonstrated in vivo through 
muscle-specific isoform deletion in mice (254). Pogozelski and colleagues 
demonstrated that the loss of the gamma isoform of p38 MAPK eliminates 
exercise-training induced increases in mitochondrial biogenesis and 
angiogenesis through the down-regulation of PGC1α and vascular endothelial 
growth factor (VEGF) (254). Furthermore, in transcripts displaying attenuated 
acute post-exercise induction there was an enrichment of genes containing the 
binding sites of NRF2, CREB and ATF2, among others, suggesting the 
downstream involvement of these proteins in p38 MAPKγ signalling. 
Conversely, p38 MAPKα and p38 MAPKβ are not required for mitochondrial 
adaptation to endurance exercise training (254).  
 
Nutrition and post-exercise energy-sensing in skeletal muscle 
  34 
As p38 MAPK responds to a myriad of stimuli, it is unsurprising that there are a 
number of mechanisms of activation. In skeletal muscle, p38 MAPK can be 
activated in response to AMPK activity (367), circulating factors (260) and 
mechanical stress (50), as well as elevations in intracellular calcium (357) as 
described in section 1.4.3.1. However, it remains inconclusive as to which 
signals are relevant during endurance exercise.  
 
Activation of p38 MAPK by AMPK activators in vitro and in vivo has suggested 
that AMPK may be an upstream regulator of p38 MAPK (180, 367). Whilst it is 
clear that both AMPK and p38 MAPK are activated in a similar time course 
post-exercise (19, 83), disconnect between the intensity-dependent 
phosphorylation and activation of AMPK (52, 83) and intensity-independence of 
p38 MAPK (83) does suggest p38 MAPK is, at least partially, regulated 
independently of AMPK during exercise. Indeed, AMPK-α2 kinase-dead mice 
display a robust p38 MAPK phosphorylation in response to exercise (131). Thus 
it is clear that skeletal muscle p38 MAPK phosphorylation does not require 
AMPK activity in response to endurance exercise. 
 
Of most promise are circulating factors elevated during exercise. Importantly, 
Widegren and colleagues have demonstrated that phosphorylation of p38 
MAPK is equally elevated in the skeletal muscle of exercising and non-
exercising legs in humans undertaking unilateral endurance exercise (347). 
These data indicate the predominance of systemic activation factors in skeletal 
muscle p38 MAPK activation during exercise. Cytokines, specifically tumour 
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necrosis factor α (TNFα), can stimulate p38 MAPK phosphorylation (185) and 
increase cellular respiration via a p38 MAPK-dependent mechanism (260) in 
C2C12 myotubes. However, during moderate endurance exercise elevations in 
IL-1 or TNFα are minimal (318), making it unlikely that these cytokines augment 
p38 MAPK phosphorylation during exercise. Conversely, circulating NEFAs can 
be increased during endurance exercise and may activate p38 MAPK through 
toll-like receptors (TLR) 2 and 4 (371). Single KO of TLR 2 and 4 ablates 
exercise and heparin (to mimic elevations in circulating NEFA without 
confounding effects of contraction) induced p38 MAPK phosphorylation (371). 
However, non-physiological suppression of NEFA availability during exercise 
does not effect post-exercise PGC1α expression in human skeletal muscle 
(331) and even elevates basal p38 MAPK phosphorylation, albeit alongside 
elevations in circulating adrenaline (344). Indeed, elevated adrenaline during 
exercise (343) represents a potential avenue of p38 MAPK activation, with 
adrenaline inducing p38 MAPK phosphorylation in vitro (343) and in vivo (93). 
Thus while indirect evidence would suggest that circulating factors activate p38 
MAPK during exercise, and that this may be reliant on TLR 2 and 4 function, it 
remains unclear which factors are stimulating this response. 
 
In conjunction with the indirect actions of p38 MAPK on PGC1α expression 
described in section 1.4.3.1 (via ATF2 and MEF2 phosphorylation), p38 MAPK 
can also acutely regulate PGC1α protein stability through direct phosphorylation 
at serine 265 and threonines 263 and 298, resulting in elevated co-
transcriptional activation (260). Each of these phosphorylation sites reside in a 
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repression region of PGC1α, whereby phosphorylation by p38 MAPK releases 
PGC1α from the transcriptional repressor molecule p160 myb binding protein 
(p160MBP), providing a mechanism for p38 MAPK mediated increases in 
PGC1α co-transcriptional activity (85, 166). Co-expression of p160MBP ablates 
the PGC1α induced increase in mitochondrial respiration and protein 
expression in C2C12 cells, an effect abolished by the addition of the cytokines 
TNFα, IL1α and IL1β (85). In vivo, p38 MAPK activation in swimming mice is 
associated with translocation of PGC1α to the nucleus and increased binding of 
NRF1 and 2 to Cyt-c and cytochrome-c oxidase (COX) IV promoters (358). 
However, similarly to AMPK, phosphorylation of PGC1α by p38 MAPK has not 
been substantiated in exercised skeletal muscle, thus the relevance of this 
potential avenue of regulation remains unclear.  
 
1.4.4 Transcriptional targets 
1.4.4.1 PGC1α  
PGC1α is a transcriptional co-activator with an important role in maintaining 
cellular metabolism. Skeletal muscle PGC1α gain-of-function promotes a shift in 
fibre-type expression towards slow-twitch fibres (187) and increases 
mitochondrial biogenesis (187, 217, 241), VO2max (42, 241) and endurance 
capacity (42, 241). Conversely, loss-of-function models show the opposite, 
adverse, phenotype (18, 179, 181). Thus, it is without question that PGC1α is 
an important metabolic regulator within skeletal muscle. 
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As has been discussed throughout this review, PGC1α is capable of integrating 
many cellular signals and co-ordinating transcription of the nuclear and 
mitochondrial genomes (Figure 1.4). PGC1α can co-ordinate mitochondrial 
biogenesis through the co-activation of thyroid hormone receptors (TRs) (261), 
oestrogen-related receptors (ERRs) (290), PPARs (342), NRFs (362), MEF2 
(187, 215) and FOXO1 (259), amongst others (90, 240). Co-activation of NRFs 
increases the transcription of oxidative genes in the nucleus (338, 358, 362) as 
well as, crucially, the mitochondrial transcription factors TFAM (54, 145, 337, 
360) and mitochondrial transcription factor B1 (TFB1M) and B2 (TFB2M) (103). 
Indeed, exercise-induced upregulation of nuclear PGC1α is accompanied by 
NRF1/2 binding to target gene promoters (358). PGC1α also resides in the 
mitochondria where it interacts with TFAM and mtDNA (275, 305). It is tempting 
to speculate that PGC1α may directly activate transcription of the mitochondrial 
genome through co-activation of TFAM (275). Furthermore, PGC1α is its own 
transcriptional activator, through MEF2 co-activation, amplifying its own 
expression and activity (122). 
 
PGC1α regulation via phosphorylation, acetylation and transcription following 
endurance exercise has been discussed frequently throughout this chapter. 
Alongside deacetylation by SIRT1 (section 1.4.2), phosphorylation by AMPK 
(section 1.4.1) and p38 MAPK (section 1.4.3.2), and elevated transcription by 
ATF2, MEF2 (sections 1.4.1 & 1.4.3.1) and CREB (see section 1.4.4.3), PGC1α 
activity is substantially governed by its subcellular location. Endurance exercise 
increases the nuclear (112, 189, 190, 245, 283, 358) and mitochondrial 
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abundance of PGC1α (275, 305). Post-exercise nuclear PGC1α content is 
coincidental with upregulation of PGC1α target genes (189, 245, 283, 358), 
while PGC1α translocation to the mitochondria is concurrent with expression of 
mitochondrially-encoded genes (275). In line with this, mRNA expression of 
PGC1α consistently increases following endurance exercise (19, 20, 83, 112, 
189, 245, 256) and is intensity-dependent (83, 256). However, PGC1α mRNA 
induction is similar between sprint-interval or high-intensity interval and 
continuous exercise (19, 112). PGC1α mRNA expression is also influenced by 
skeletal muscle glycogen content (20), an unsurprising finding given the 
influence of AMPK activity on PGC1α regulation. 
 
Mouse and human skeletal muscle express several PGC1α isoforms. 
Transcription can originate from the canonical promoter to produce PGC1α-a 
and from alternative promoters to produce PGC1α-b and PGC1α-c (216, 369), 
although PGC1α-c is lowly expressed in human skeletal muscle (255, 256). 
Alternative splicing can also generate N-truncated (NT) isoforms of PGC1α (13, 
373). At rest, PGC1α expression in human skeletal muscle is regulated only via 
the canonical promoter (228, 255, 256). However, endurance exercise in 
humans does not substantially increase PGC1α expression from the canonical 
promoter (producing PGC1α-a) (255, 256, 299). Instead expression from the 
alternative promoter (producing PGC1α-b) predominates (255, 256, 364) and 
confers the intensity-dependence of PGC1α mRNA expression (256).  
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Despite all the evidence for a central role in mitochondrial biogenesis, PGC1α is 
not required for exercise-induced mitochondrial biogenesis within skeletal 
muscle (18, 179, 272). Acute endurance exercise induces comparable 
increases the mRNA expression of COX5b, a known PGC1α target gene, in 
PGC1α and WT mice (272). 12 days of VWR in WT and PGC1α mKO mice 
equally upregulated NRF1, TFAM, COX5a and ATP synthase subunit 5o 
(ATP5o) (272). Furthermore, no deficits in exercise training induced 
mitochondrial density or electron transport complex activity were apparent in 
PGC1α mKO mice (272). The same group have subsequently shown that 
inducible PGC1α and PGC1β double mKO, thereby reducing the possibility of 
developmental or PGC1β driven compensation, are also responsive to 
endurance exercise training (18). In human skeletal muscle, acute PGC1α 
mRNA induction does not correlate with training-induced mitochondrial 
biogenesis (109). Thus, although PGC1α is certainly central to many exercise-
induced adaptations, other transcriptional processes certainly occur 
concurrently, independently and/or in concert with PGC1α, and can 
compensate for a loss of PGC1α. 
 
1.4.4.2 p53 
The tumour-suppressor protein and transcription factor p53 has recently been 
purported to play a role in regulating mitochondrial biogenesis in skeletal 
muscle. This additional role of p53 is hardly surprising given its ubiquitous 
regulatory activity in cell-cycle arrest, apoptosis, angiogenesis, DNA repair, 
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metabolism, signal transduction, translation and transcription (183, 227). In cell 
culture models of various tissues, p53 is implicated in the transcriptional control 
of the mitochondrial biogenic proteins PGC1α, TFAM, cytochrome-c assembly 
protein (SCO2), apoptosis-inducing factor (AIF), mitofusin 2 (MFN2) and DRP1 
(11, 184, 202, 239, 312, 341) and is also required for the maintenance of 
mtDNA copy number (169, 177). 
 
Whole-body KO of p53 reduces endurance capacity and increases lactate 
production during submaximal exercise, while also impairing the increase in 
work capacity and VO2peak in response to endurance training (239, 281). p53 KO 
also impairs basal skeletal muscle mitochondrial content, mitochondrial 
morphology, mtDNA copy number, COX activity, mitochondrial respiratory 
capacity and apoptosis (239, 281, 284). Thus it is unequivocal that whole-body 
ablation of p53 impairs skeletal muscle mitochondrial function and endurance 
capacity. However, contradictory evidence arises when studying the molecular 
basis of this within skeletal muscle. Basal protein expression of PGC1α in p53 
KO mice has been reported to either decrease (281) or remain unchanged 
(239) compared to WT littermates, although both groups do report a decrease 
in TFAM and NRF1 mRNA expression (239, 282). Additionally, Saleem and 
colleagues report p53 KO ablates or impairs exercise-induced upregulation of 
PGC1α, TFAM, NRF1, complex IV and complex I (282, 283) while, conversely, 
Park et al (239) found no impairment of exercise-induced gene expression on 
transcriptional regulators (PGC1α, PGC1β, NRF1, NRF2, TFAM), nuclear-
encoded genes (Cyt-c, complex IV) or mitochondrially-encoded genes (complex 
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II, mitochondrially encoded NADH reductase 1 (mtND1)). Ultimately, p53 KO 
mice display a robust mitochondrial biogenic response to eight weeks of VWR, 
despite reduced running distance (281). Thus, while the role of p53 in the 
regulation of acute-exercise induced pro-mitochondrial gene expression 
remains contradictory and unclear, p53 is unnecessary for chronic mitochondrial 
adaptations to endurance training. 
 
If p53 is contributing to the regulation of post-exercise mitochondrial biogenesis 
then alterations in post-translational modifications and/or subcellular location of 
p53 should occur with exercise. AMPK and p38 MAPK mediated 
phosphorylation of p53Ser15 leads to increased p53 stability, nuclear 
accumulation and transcriptional activity (10, 37, 154). Skeletal muscle p53Ser15 
phosphorylation occurs following electrical stimulation in mice (281), continuous 
and intermittent exercise in humans (19, 20, 112) and can be accentuated 
following exercise in a glycogen-depleted state (20). This post-exercise 
phosphorylation occurs in a time course concurrent with alterations in AMPK 
and p38 MAPK signalling (19, 112, 281). However, p53 phosphorylation 
following exercise in a glycogen-depleted state occurred in the absence of 
altered p38 MAPK phosphorylation, but in parallel to an increase in AMPK 
signalling, suggesting AMPK may be the predominant upstream kinase 
regulating post-exercise p53 phosphorylation (20).  
 
To date, the effect of acetylation status on p53 activity in skeletal muscle or in 
relation to mitochondrial biogenesis remains largely unknown. Following 
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exercise, pan-acetylation of p53 decreases in nuclear fractions of skeletal 
muscle, indicative of elevated SIRT1 activity (245). In mouse embryonic stem 
cells, reactive oxygen species (as produced during exercise) trigger p53 
deacetylation, translocation of p53 to the mitochondria and subsequent 
apoptosis in a SIRT1-dependent manner (121). Indeed, p53 has been reported 
to translocate to the mitochondria following endurance exercise in rodents (274, 
283), where it plays a role in mtDNA-stability and apoptosis (274, 281). Within 
the mitochondria of exercised mice, p53 complexes with polymerase γ 1 
(POLG1), TFAM and mtDNA (274, 283) and mediates maintenance of mtDNA 
stability in vitro (274). Furthermore, the attenuation of age-related mtDNA 
damage and mitochondrial dysfunction by endurance exercise in mtDNA 
mutator mice is ablated when mtDNA mutator mice have additional p53 mKO 
(274). This suggests a substantial role of exercise-induced p53 mitochondrial 
translocation in maintaining mitochondrial integrity in these animals and it would 
be interesting to know whether this also occurs in healthy models of ageing. 
 
Nuclear content of p53 has also been reported to increase post-exercise (112, 
248, 320), accompanied by an increase in PHD finger protein 20 (PHF20), a 
regulator of p53 stability and transcriptional activity (112). It is attractive to 
speculate that p53 could then act as a transcription factor. Following fasting in 
mouse skeletal muscle, p53 releases from inhibitory response elements on the 
PGC1α promoter and binds instead to an activating region, increasing the 
expression of PGC1α and antioxidant genes (11). Conversely, it has also been 
reported that following acute endurance exercise p53 translocates away from 
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the nucleus (274, 283). The divergent responses measured in the above 
studies could be explained by the severity of the exercise, as ROS production 
induces p53 accumulation in mitochondria (121, 274). In the study by Saleem 
and Hood (283) mice were exercised to exhaustion, a situation that likely 
involves a large accumulation of oxidative stress (258) and could explain 
nuclear export and mitochondrial localisation of p53 for mtDNA stability (274) 
and/or apoptosis (121). Conversely, in less severe models of endurance 
exercise (112, 248, 320) p53 may translocate to the nucleus, possibly to 
promote PGC1α expression (11). 
 
p53 also impacts on kinase activity, acting upstream of AMPK, p38 MAPK and 
CAMKII, therefore influencing nutrient sensing and signal transduction. Saleem 
et al (282) have demonstrated that whole-body knockout of p53 delays post-
exercise AMPK signalling; such that no increase in AMPK phosphorylation was 
apparent immediately post-exercise. Furthermore, CAMKII phosphorylation was 
delayed and attenuated while p38 MAPK phosphorylation is completely ablated 
post-exercise (282). Interestingly, PGC1α nuclear translocation was also 
delayed, possibly consequently to impaired AMPK, p38 MAPK and CAMKII 
signalling, and may contribute to the apparent attenuation or delay in 
upregulation of genes involved in mitochondrial biogenesis (282).  
 
Exercise training can upregulate skeletal muscle p53 protein content, in an 
exercise intensity-dependent manner (111). Following four weeks of sprint 
interval training (4-10 x 30-s all-out sprints, ~200% Wmax, 3 times per week), but 
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not high-intensity interval training (4-7 x 4-min intervals at ~90% Wmax) or 
continuous exercise (20-36 minutes at ~65% Wmax), basal p53 protein increases 
approximately two-fold. Furthermore, PHF20 also increased following sprint 
interval training providing a novel potential mechanism of p53 upregulation by 
exercise training. However, protein content of TFAM, MFN2, DRP1 and AIF, 
known downstream transcriptional targets of p53, either remained unchanged 
with training or showed no dependence on exercise intensity and therefore p53 
protein content (111). Thus while this study provides interesting evidence of a 
regulation of skeletal muscle p53 protein content by sprint exercise, the 
implications of this remain unclear. 
 
1.4.4.3 CREB 
It has previously been documented during exercise with normal and low pre-
exercise glycogen that the catecholamine adrenaline is increased within the 
circulation (70, 319, 343). One action of the increased circulating adrenaline is 
the activation of β-adrenergic receptors and subsequent cAMP accumulation 
that activates the protein kinase A (PKA) pathway. Endurance exercise has 
long been known to increase cAMP concentrations in murine skeletal muscle 
(36, 105, 266). Furthermore, this effect appears intensity-dependent (105). 
 
A number of observations associate β-adrenergic/cAMP/PKA signalling with 
acute and chronic metabolic regulation of skeletal muscle. Firstly, β-adrenergic 
receptors are enriched in oxidative type I fibres compared with type II fibres in 
both rodents and humans (86, 201, 351). Furthermore, induction of cAMP in 
General Introduction: Energy-sensing in skeletal muscle 
 45 
muscle cells induces the expression of mitochondrial enzymes (176). 
Conversely, impairment of β-adrenergic signalling in skeletal muscle impairs 
PGC1α expression and mitochondrial adaptations to endurance exercise (216, 
218, 319, 321). Of particular note, treatment with the β-adrenergic receptor 
blocker propranolol impairs the improvement in the enzyme activities of 
cytochrome-c oxidase and 3-hydroxyacyl-CoA dehydrogenase (β-HAD), but not 
citrate synthase (CS) or succinate dehydrogenase, induced by eight weeks of 
endurance training in humans (319). 
 
Elevated cellular cAMP concentrations activate PKA (340). Skeletal muscle 
PKA activity is increased by endurance exercise in mice and rainbow trout (211, 
352). In murine skeletal muscle exercise-induced phosphorylation of CREB is 
ablated by PKA inhibition, supporting a role of cAMP-induced PKA activation in 
mammalian skeletal muscle (266). Furthermore, in an unbiased phosho-screen 
using tandem mass spectrometry and annotated kinase-substrate relationships, 
phosphorylation of seventeen known PKA substrates was enhanced in human 
skeletal muscle following high-intensity exercise (85-92% Wmax for ~10 
minutes), strongly suggesting elevated PKA activity (132). 
 
The effect of endurance exercise on CREB phosphorylation varies substantially 
with some studies reporting immediate post-exercise serine 133 
phosphorylation (36, 245, 256, 266), dephosphorylation (83), delayed (~3-19h 
post-exercise) phosphorylation (83) or no change (347, 348). Interestingly in a 
human unilateral exercise model immediate post-exercise CREBSer133 
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phosphorylation was elevated in the non-exercising contralateral leg but not in 
the exercising leg (347). However, this is not a universal finding, which may be 
related to exercise intensity and/or duration (348). If CREB can be activated in 
non-exercising muscle and simultaneously remain unchanged in exercising 
muscle, this would suggest that while humeral factors such as adrenaline 
stimulate CREB phosphorylation, local (as yet undetermined) contraction or 
metabolic-mediated factors may suppress CREBSer133 phosphorylation during 
exercise. Indeed, the trade-off between systemic activators and local 
suppressors may explain the variation in CREB phosphorylation apparent 
immediately post-exercise. Sustained elevation of CREB phosphorylation 
during the post-exercise recovery period (83) may be permissive for continued 
elevation of PGC1α expression up to eight hours after exercise (339), whilst 
basal CREBSer133 phosphorylation has been reported to increase with exercise 
training in mice (238). 
 
In endurance-trained humans, RNA-seq analysis of two participants’ response 
to 65 minutes of endurance exercise at 70% VO2max identified the upregulation 
of CREB-dependent genes, in contrast to a lack of regulation of MEF2-
dependent genes (256). qPCR analysis in ten participants confirmed an 
intensity-dependent effect of exercise on a subset of the CREB-dependent 
genes, mirroring the intensity-dependence of CREBSer133 phosphorylation 
apparent in this study. Furthermore, this was concomitant with intensity-
dependent expression of exon b1-derived (alternative promoter) PGC1α mRNA 
four hours post-exercise (256), a promoter region containing a CRE binding site 
General Introduction: Energy-sensing in skeletal muscle 
 47 
(369). Thus it could be inferred that exercise-induced activation of CREB may 
be, at least partially, responsible for the post-exercise expression of PGC1α 
from the alternative promoter, supporting stimulated muscle cell and exercising 
rodent data of β-adrenergic/cAMP/PKA/CREB regulation of this splice variant 
during exercise (216, 321, 345, 369). Nonetheless this evidence is far from 
conclusive, given the extremely low sample size for the RNA-seq analysis and 
the possibility that additional CREB-like transcription factors, such as ATF2, 
may regulate the same transcripts and binding sites. 
 
Phosphorylation of CREBSer133 increases CREB transcriptional activity through 
association with the histone acetyltransferases CBP and p300 (55, 108, 198), 
allowing for histone acetylation and polymerase II complex recruitment (159, 
232). CREB stimulates gene transcription at promoters containing the CRE 
binding motif, including PGC1α (122). However, while CREBSer133 
phosphorylation appears to be required for CREB activation it may not be 
sufficient, with phosphorylation at serine 142 by CAMKII, opposing the 
expression of CREB sensitive genes (194). CREBSer142 phosphorylation is yet to 
be investigated in skeletal muscle and thus represents an interesting additional 
level of regulation requiring further study.  
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Figure 1.4 Energy- and contractile-sensing pathways orchestrate 
mitochondrial biogenesis within skeletal muscle 
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Exercise alters the cellular milieu of skeletal muscle. Alterations in AMP, 
glycogen, NAD+, Ca2+, cAMP and activation of membrane receptors activate 
AMPK, SIRTs, CAMKII, PKA and p38 MAPK during exercise. These 
interconnected signalling pathways converge on transcription factors and co-
activators such as MEF2, ATF2, CREB, p53 and PGC1α to induce 
mitochondrial biogenesis. PGC1α particularly can co-ordinate the expression of 
both nuclear and mitochondrial genomes via co-activation and induction of 
PPARs, ERRs, NRFs, MEF2, CREB and TFAM. Chronic activation of these 
signalling pathways results in mitochondrial biogenesis and a greater capacity 
for aerobic ATP production. 
 
1.5 Nutritional strategies to augment skeletal muscle signalling and 
mitochondrial biogenesis 
 
1.5.1 Energy restriction per se increases activity of energy-
sensing proteins and mitochondrial biogenesis within 
skeletal muscle 
Skeletal muscle has the flexibility to switch between fuel sources dependent 
upon energy requirement and availability. In this respect fasting induces 
elevations in fat oxidation to spare carbohydrate and preserve blood glucose 
levels for glucose-dependent tissues such as the brain (41, 349, 350). 
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Like exercise, fasting alters the metabolic environment of skeletal muscle cells. 
In fasted murine skeletal muscle, elevations in cellular AMP and depletion of 
glycogen activates AMPK (45, 71, 115, 314) and increased NAD+ 
concentrations promote SIRT1-deacetylase activity (45, 98). Together, these 
induce deacetylation, activation and expression of PGC1α and induction of 
metabolic and mitochondrial genes (45, 98, 115). However, these effects do not 
consistently occur in human skeletal muscle, likely due to the higher glycolytic 
reliance in murine skeletal muscle and therefore greater energetic stress during 
fasting. In human skeletal muscle, 10-48 hours of fasting does not result in 
glycogen depletion (80, 203) or increase the phosphorylation of AMPKThr172, 
ACCSer79 or p38 MAPKThr180/Tyr182 (80, 349, 350), while PGC1α mRNA 
expression actually decreases 24-48 hours into fasting (80, 349, 350). 
However, from the time points analysed it cannot be excluded that these 
markers may show transient activation in the immediate hours following the 
onset of fasting. Phosphorylation of CREBSer133 does, however, increase with 
fasting (349). SIRT1 can also be moderately activated by fasting in human 
skeletal muscle, with Edgett et al (80) finding small elevations in SIRT1 mRNA 
and deacetylation of p53 after 48 hours. Fasting does consistently amplify the 
expression of PDK4 mRNA in human skeletal muscle (80, 251, 310, 349, 350), 
suggesting the fasting induced activation of PPARα may be conserved from 
rodents to humans (161). Furthermore, the mRNA of processes involved in fatty 
acid metabolism are overexpressed in skeletal muscle following 10 hours of 
fasting (349). 
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1.5.2 Exercising in the fasted state alters metabolism and may 
increase post-exercise skeletal muscle signalling and 
mitochondrial biogenesis 
As has been previously highlighted, performing exercise in a glycogen-depleted 
state augments AMPKThr172 phosphorylation, AMPK nuclear abundance, 
AMPKα2 activity, PGC1α nuclear abundance and PGC1α expression (20, 171, 
247, 316, 356, 365). Furthermore, performing exercise training in a glycogen-
depleted state, via twice-daily training, augments training-induced mitochondrial 
biogenesis (123, 366) and skeletal muscle lipid metabolism (142). However, the 
practicality of depleting glycogen and then subsequently exercising could be 
questioned for implementation in the general population. A more achievable 
method of increasing energetic stress during exercise may be to undertake 
endurance exercise following an overnight fast. 
 
Moderate-intensity (50-75% VO2peak) exercise performed in the fasted state 
increases systemic fatty acid availability, intramyocellular lipid utilisation and 
whole-body fat oxidation compared to exercise combined with carbohydrate 
ingestion (3, 5, 51, 57, 58, 70, 81, 336). Despite this, glycogen utilisation is 
similar in fed or fasted exercise (5, 70) suggesting that the metabolic effects 
observed following fasting are not mediated by glycogen availability. Systemic 
insulin concentrations are lower during fasted versus fed exercise (3, 51, 58, 
70), while circulating adrenaline increases during fasted but not fed exercise (3, 
70). 
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As might be expected from a less severe model of energetic stress, the effects 
of exercising in the fasted state on post-exercise signalling and mitochondrial 
biogenesis are more modest and less consistent than glycogen-depleted 
exercise training. Fasted exercise has been demonstrated to augment post-
exercise AMPKα2 activity (5), although no differences in AMPKThr172 or 
ACCSer79 phosphorylation have been reported (5, 70, 293), whilst elevated 
AMPKThr172 phosphorylation following fed-state exercise may also be apparent 
(81). Downstream, post-exercise mRNA expression of AMPKα2 and the 
metabolic genes PDK4, GLUT4 and UCP3, but not PGC1α, are inhibited by 
glucose ingestion during exercise (57, 58).  
 
Moderate-intensity (65-70% VO2peak) endurance training performed in the fasted 
state upregulates activity of the mitochondrial enzymes CS and β-HAD 
compared to carbohydrate-fed exercise in recreationally active males (313, 
334). Conversely, improvements in CS and β-HAD activity are similar when 
overweight/obese females perform high-intensity interval training in the fed and 
fasted states (101). However, sex-based differences may occur as fasting has 
been shown to augment the increase in CS activity following endurance 
exercise training in males but not females (313). Furthermore, when comparing 
positive benefits of combining fasting with continuous but not high-intensity 
interval training (101, 334), it is possible that the duration of exercise and the 
degree and manner of fuel utilisation is an important consideration in the 
efficacy of fasted endurance exercise.  
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To date research investigating the effect of fed versus fasted exercise on post-
exercise skeletal muscle signalling responses have, understandably, focussed 
primarily upon AMPK. However, as has been outlined throughout this review, a 
multitude of other signalling pathways are potentially sensitive to the elevated 
energetic stress during fasted exercise and remain to be assessed. 
Hypothetically, fasted exercise could alter skeletal muscle NAD+ concentrations 
and SIRT/PARP signalling, while p38 MAPK and CREB signalling cascades 
could be modulated by altered circulating FFAs, adrenaline and differential 
AMPK activation. Thus the potential additive or synergistic effect of combining 
fasting with exercise on signalling pathways within human skeletal muscle 
remains incompletely understood. 
 
1.5.3 Niacin elevates skeletal muscle NAD+ concentrations; 
promoting sirtuin signalling and mitochondrial biogenesis 
The mitochondrial biogenic effects of a myriad of chemical compounds and 
naturally occurring nutraceuticals, many of which ‘mimic’ the effects of energy 
restriction, have been examined in isolation and in combination with endurance 
exercise. A thorough review of all these compounds is outside the scope of this 
review (see (67, 73) for comprehensive reviews), instead the effects and 
efficacy of several forms of niacin (vitamin B3) will be discussed given their 
ability to modify systemic and skeletal muscle NAD+ bioavailability. 
 
Niacin is present in many foods and relatively small doses of niacin (~15 mg per 
day) or tryptophan prevent pellagra. Much higher doses of NA (~2-4 g per day) 
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are used to treat dyslipidaemia (104). NAM, NA and NR can each increase 
cellular and mitochondrial NAD+ concentrations in vivo, including within skeletal 
muscle (44, 328). Increasing cellular NAD+ via niacin supplementation in vivo 
leads to positive outcomes in models of diabetes (264, 368), ageing (72, 213, 
264), obesity (44), vascular dysfunction (72), muscular dystrophy (273) and 
Alzheimer’s disease (196).  
 
Acipimox, a derivative of NA, enhances skeletal muscle mitochondrial function 
in type II diabetics (333). However, high-dose supplementation of NA can result 
in painful flushing, while NAM supplementation may cause liver damage (29). 
NA and NAM supplementation also blunt adipose tissue lipolysis and whole-
body fat oxidation through NA binding to niacin receptor 1 (GPR109A) in 
adipocytes (94, 322, 330, 344). Furthermore, high-doses of NAM actually inhibit 
SIRTs (23). Conversely, NR treatment does not activate GPR109A, while 
supplementation increases fat oxidation and metabolic flexibility in mice (44, 
297). Interestingly, this is in spite of the main circulatory product of oral NR 
supplementation in mice being NAM (192). Oral NR supplementation appears 
to undergo almost complete first-pass metabolism in the murine liver, with 
exogenous NR-derived myocellular NAD+ likely formed via extracellular NAM 
(192). Despite this, elevated systemic NR (4), as well as NAM (328), 
concentrations have been noted following NR supplementation in humans. 
Thus NR is emerging as a promising way to boost cellular NAD+ via high-dose 
niacin supplementation. 
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NR treatment in vitro and in vivo activates skeletal muscle SIRT1 and SIRT3, 
but not PARP1, resulting in deacetylation of PGC1α and FOXO1 and 
subsequent mitochondrial biogenesis (44, 47, 162, 273). Accordingly, NR 
supplementation in mice increases endurance performance, insulin sensitivity 
and protects against the metabolic consequences of a high-fat diet (44, 273). 
NR treatment can promote mitochondrial biogenesis and attenuate disease 
progression in murine models of mitochondrial disease (47, 162), with the 
effects much more pronounced in models with a metabolic challenge (44, 47, 
162). In such conditions, it may be that pervasion of dysfunctional mitochondria 
simply provides a greater opportunity for improvement. Additionally, NR is likely 
to be more effective in situations where NAD+ content is dysregulated such as 
during high-fat feeding (92) or with mitochondrial myopathy (162). Nonetheless, 
this highlights the promising role of NR supplementation in the treatment of 
metabolic and mitochondrial diseases. 
 
To our knowledge no study to date has combined NR supplementation with 
exercise training. However, elevating skeletal muscle NAD+ concentration via of 
overexpression of NAMPT, the rate-limiting enzyme in NAD salvage, augments 
VWR-induced improvements in endurance capacity in mice (65). This effect is 
not seen in sedentary mice (65, 92). Thus, elevating NAD+ concentrations 
appears more effective in combination with exercise. This lends further support 
to the hypothesis that elevating NAD+ concentrations, either genetically or 
nutritionally, is likely to be more effective during conditions of cellular stress, as 
substantial NAD+ turnover occurs during exercise (346). 
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NR supplementation studies in humans are in their infancy (4, 74, 78, 200, 
328). Importantly, NR supplementation in humans has been shown to be safe 
and does not result in flushing (4, 74, 78, 200, 328). Charles Brenner first 
demonstrated the bioavailability of 1000 mg·d-1 of NR on himself and then on a 
cohort of participants (328). A single dose of NR can enhance NAD+ in 
peripheral blood mononuclear cells (PBMCs) and plasma within five hours and 
repeated daily dosing stabilises the elevated NAD+ concentrations (328). 
Furthermore, in the n=1 experiment the rise in NAD+ was concomitant with an 
increase in ADPR, suggestive of increased NAD+-consuming processes (328). 
Furthemore, NAD+ concentration in red blood cells is dose-dependently 
increased by co-supplementation of NR and pterostilbene, a polyphenol, (500 > 
250 > 0 mg·d-1 of NR) in healthy elderly participants (74).  
 
Data regarding the effect of NR supplementation on health parameters in 
humans are beginning to emerge (74, 78, 200). Dellinger and colleagues report 
that 60-days of 500 mg·d-1 NR and 100 mg·d-1 of pterostilbene ingestion 
improved physical function (30-s chair test and 6-min walk test), as well as 
indications that co-ingestion of NR and pterostilbene could improve liver health 
(74). Conversely, Martens et al (200) report no effect of 6-weeks of 1000 mg·d-1 
NR supplementation on physical function, VO2max or substrate utilisation during 
exercise in middle aged and elderly participants, although reductions in blood 
pressure were apparent. Finally, both Martens et al (200) and Dollerup et al (78) 
have demonstrated that NR supplementation for 6 and 12 weeks, respectively, 
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Endurance exercise activates a myriad of interconnecting cellular energy and 
contractile sensors that converge on downstream transcriptional regulators. The 
repeated activation of these pathways controls the induction of mitochondrial 
biogenesis, muscle function and, ultimately, whole-body health. Almost all of 
these signalling cascades can be targeted by altering the exercise environment, 
be that via intensity, duration or intermittency of exercise or by altering the 
nutritional environment (i.e. fasting or nutraceuticals) that exercise is performed 
in. Particularly, exercising in an energy (or carbohydrate)-restricted state 
represents an achievable and affordable strategy to maximise post-exercise 
signalling and, potentially, skeletal muscle adaptations to endurance exercise. 
 
Nonetheless, like any scientific field, the picture is not yet complete. Particularly, 
this thesis will attempt to further understand the importance and role of p53 in 
skeletal muscle mitochondrial biogenesis and to elucidate effective nutritional 
strategies to augment post-exercise skeletal muscle signalling. As discussed, 
the current role of p53 in skeletal muscle is unclear and confounded by the 
reliance upon evidence from other tissues and from whole-body p53 KO mice. 
Thus, we will employ an mKO model of p53 deletion to ascertain the muscle-
specific role of p53 in mitochondrial biogenesis. Furthermore, we will investigate 
how fasting and the fasting mimetic NR influences post-exercise skeletal 
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muscle signalling. Currently, the mechanisms linking fasted exercise to elevated 
training-induced mitochondrial biogenesis are unclear. While AMPK appears to 
be activated to a greater degree in the fasted state, other pathways remain to 
be examined. Particularly the effect of fasted exercise on sirtuin signalling has 
yet to be investigated in human skeletal muscle. Additionally, promising 
evidence for a positive effect of NR supplementation on mitochondrial 
biogenesis is apparent in cell and rodent models. However, research in human 
populations remains in the early stages and the potential additive or synergistic 
effect of NR supplementation and endurance exercise has not been 
investigated. 
 
1.7 Research Aims 
1. Investigate the effect of muscle-specific deletion of p53 on skeletal 
muscle mitochondrial and metabolic enzyme content and function 
 
2. Investigate how energy restriction in combination with moderate- to high-
intensity steady-state exercise can influence post-exercise energy-
sensing pathways in humans 
 
3. Investigate how NR supplementation influences metabolism and post-
exercise energy-sensing pathways within human skeletal muscle 
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2.1 Abstract 
Tumour protein 53 (p53) has been implicated in the regulation of mitochondrial 
biogenesis in skeletal muscle, with whole-body p53 knockout mice displaying 
impairments in basal mitochondrial content, respiratory capacity and enzyme 
activity. This study aimed to determine the effect of skeletal muscle-specific loss 
of p53 on mitochondrial content and enzyme activity. Mitochondrial protein 
content, enzyme activity and mRNA profiles were assessed in skeletal muscle 
of eight-week-old male muscle fibre-specific p53 knockout mice (p53 mKO) and 
floxed littermate controls (WT) under basal conditions. p53 mKO and WT mice 
displayed similar content of electron transport chain proteins I-V and maximal 
citrate synthase enzyme activity in skeletal muscle. In addition, the content of 
proteins regulating mitochondrial morphology (MFN2, mitofillin, OPA1, DRP1, 
FIS1), fatty acid metabolism (β-HAD, ACADM, ACADL, ACADVL), carbohydrate 
metabolism (HKII, PDH), energy sensing (AMPKα2, AMPKβ2) and gene 
transcription (NRF1, PGC1α and TFAM) were comparable in p53 mKO and WT 
mice (p > 0.05). Furthermore, p53 mKO mice exhibited normal mRNA profiles of 
targeted mitochondrial, metabolic and transcriptional proteins (p > 0.05). Thus it 
appears that p53 expression in skeletal muscle fibres is not required to develop 
or maintain mitochondrial protein content or enzyme function in skeletal muscle 
under basal conditions. 
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2.2 Introduction 
Tumour protein p53 (p53) was initially characterised as a tumour suppressor 
protein (9, 10, 25), serving to regulate cellular metabolism and proliferation (1, 
9, 27). More recently, a functional role of p53 for in vivo skeletal muscle 
physiology has been proposed, following observations that p53 can regulate 
apoptosis (18), atrophy (5), autophagy (19), mitochondrial DNA (mtDNA) 
stability (17, 20), post-exercise signalling (18, 19), mitochondrial function (12, 
18, 19, 26) and endurance performance (12, 18, 26) within skeletal muscle. 
 
Whole-body knockout (KO) of p53 in mice results in a deficient skeletal muscle 
mitochondrial phenotype (12, 18), displaying reduced mitochondrial mass, 
mtDNA copy number, cytochrome-c oxidase (COX) enzyme activity and state 3 
respiration (12, 18). As a consequence, endurance capacity and voluntary 
wheel running are also reduced in p53 KO mice (12, 18). In comparison, 
oncogenic p53 mutations found in the Li-Fraumeni syndrome increase in vivo 
skeletal muscle oxidative phosphorylation in humans (26), while mitochondrial 
respiration and content of electron transport chain proteins is increased in 
primary myoblasts from Li-Fraumeni carriers and in mice carrying a p53 R712H 
polymorphism (26). Thus it is clear that p53 plays an important role in 
mitochondrial metabolism and function. 
 
Whilst loss of p53 impairs mitochondrial function, importantly, p53 KO mice still 
respond to endurance exercise training (18). Specifically, p53 KO and WT mice 
display similar increases in COX activity with training, while trained p53 KO 
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mice exhibit no difference in electron micrograph determined subsarcolemmal 
mitochondrial density compared to trained WT mice (18). This suggests that 
p53 is not essential for endurance exercise induced mitochondrial adaptations 
(17, 18), and the functional deficits of p53 KO appear to arise in the basal (i.e. 
non-exercised) state. 
 
Despite the wealth of evidence that p53 is important for whole-body metabolism 
and skeletal muscle mitochondrial function, determining the importance of p53 
specifically in skeletal muscle cannot be ascertained from models of whole-
body p53 deletion. In such models, it cannot be excluded that phenotypic 
differences in skeletal muscle physiology may arise as secondary defects due 
to dysfunction induced by the loss of p53 in other cell types. Thus to elucidate 
the role of p53 specifically within skeletal muscle fibres, this study determined 
the effect of skeletal muscle fibre-specific loss of p53 (mKO) on mitochondrial 
content and enzyme activity in skeletal muscle. 
 
2.3 Methods 
2.3.1 Mouse model development 
The development and validation of the p53 mKO mouse has been described 
previously (5). Briefly, p53 mKO mice were generated by crossing homozygous 
p53 floxed mice (p53f/f; exons 2–10 of the p53 gene are flanked by LoxP 
restriction sites) with mice expressing cre recombinase under the control of the 
muscle creatine kinase (MCK) promoter. Control mice (WT) were p53f/f 
littermates that lack the MCK-cre recombinase transgene. All mice were on a 
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C57BL/6 background. Eight-week old male mice were used for all experiments. 
Mice were housed in colony cages at 21°C with 12:12-h light-dark cycles and 
ad libitum access to standard laboratory chow (Harlan-Teklad formula 7913) 
and water. All animal procedures were approved by the Institutional Animal 
Care and Use Committee of the University of Iowa. 
 
2.3.2 Tissue collection and preparation 
Muscle was obtained from young (8-weeks old), healthy mice under basal 
conditions. Gastrocnemius, quadriceps and triceps muscle was rapidly 
dissected and rinsed to remove blood and fur before being snap-frozen in liquid 
nitrogen. Muscle was powdered using a Cellcrusher tissue pulverizer 
(Cellcrusher, Co. Cork, Ireland) on dry ice and stored at -80°C prior to analysis.  
 
2.3.3 Immunoblotting 
Tissue was homogenised in a 10-fold mass excess of ice-cold sucrose lysis 
buffer (50 mM tris, 1 mM EDTA, 1 mM EGTA, 50 mM NaF, 5 mM Na4P2O7-
10H2O, 270 mM sucrose, 1 M triton-X, 25 mM β-glycerophosphate, 1 µM 
trichostatin A, 10 mM nicotinamide, 1mM 1,4-dithiothreitol, 1% phosphatase 
inhibitor cocktail 2; Sigma, 1% phosphatase inhibitor cocktail 2; Sigma, 4.8% 
cOmplete mini protease inhibitor cocktail; Roche) by shaking in a FastPrep 24 
5G (MP Biomedicals, Santa Ana, California, USA) at 6.0 m·s-1 for 80 s and 
centrifuging at 4°C and 8000 g for 10 min to remove insoluble material. Protein 
concentrations were determined by the DC protein assay (Bio-Rad, Hercules, 
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California, USA). Samples were boiled at 97°C for 5 min in laemmli sample 
buffer and an equal volume of protein (20-50 µg) was separated by SDS-PAGE 
on 8 - 12.5% gels at a constant current of 23 mA per gel. To demonstrate the 
loss of p53 in mKO skeletal muscle, the triceps muscle from mKO and WT mice 
were immunoblotted. Gastrocnemius, quadriceps and triceps muscle were all 
immunoblotted to examine the effect of p53 mKO on the content of 
mitochondrial, metabolic, signalling and transcriptional proteins. The presented 
data is from gastrocnemius muscle. Proteins were transferred on to BioTrace 
NT nitrocellulose membranes (Pall Life Sciences, Pensacola, Florida, USA) via 
wet transfer at 100 V for one hour. Membranes were then stained with Ponceau 
S (Sigma-Aldrich, Gillingham, UK) and imaged to check for even loading. 
Membranes were blocked in 3% dry-milk in tris-buffered saline with tween 
(TBST) for one hour before being incubated in primary antibody overnight at 
4°C. Membranes were washed in TBST three times prior to incubation in 
appropriate horse radish peroxidase-conjugated secondary antibody at room 
temperature for one hour. Membranes were then washed in TBST three times 
prior to antibody detection via enhanced chemiluminescence horseradish 
peroxidase substrate detection kit (Millipore, Watford, UK). Imaging and band 




All primary antibodies were used at a concentration of 1:1000 in TBST unless 
otherwise stated. Antibodies: 3-hydroxyacyl-CoA dehydrogenase (β-HAD; 
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37673), Mitofillin (110329) and MitoProfile OXPHOS antibody cocktail (110413) 
from abcam; cytochrome-c (Cyt-c; 556433) from BD Pharmingen; 5' AMP-
activated protein kinase alpha (AMPKα; 2603), AMPKβ2 (4148), dynamin-1-like 
protein (DRP1; 8570), glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 
2118; 1:5000), eukaryotic elongation factor 2 (eEF2; 2332), hexokinase II (HKII; 
2867), mitofusin 2 (MFN2; 9482), pyruvate dehydrogenase (PDH; 2784) and 
p53 (2524; 1:1000 in 5% non-fat dry milk in TBST) from Cell Signaling 
Technologies; dynamin-like 120 kDa protein (OPA1; CPA3687) from Cohesion 
Biosciences; peroxisome proliferator-activated receptor gamma coactivator 1-
alpha (PGC1α; ST1202) from EMD Millipore; citrate synthase (CS; 
SAB2701077), mitochondrial fission protein 1 (FIS1; HPA017430; 1:500) and 
mitochondrial transcription factor A (TFAM; SAB1401383) from Sigma-Aldrich; 
acyl-CoA dehydrogenase medium chain (ACADM; 1:2000), acyl-CoA 
dehydrogenase long chain (ACADL; 1:5000), acyl-CoA dehydrogenase very 
long chain (ACADVL; 1:5000) were kind gifts from Prof Jerry Vockley, University 
of Pittsburgh, USA. Secondary antibodies were used at a concentration of 
1:10000 in TBST. Anti-rabbit (7074) and anti-mouse (7076) antibodies were 




Tibialis anterior skeletal muscle was embedded and frozen in tissue freezing 
medium (Triangle Biomedical, Durham, North Carolina, USA) in nitrogen-cooled 
isopentane, muscle samples were stored at -80°C. Skeletal muscle cross 
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sections (7 µM) of WT and mKO tibialis anterior muscle (6 sections per mouse, 
n = 3 per group) were prepared using a microtome blade (Bright 5040, Bright 
Instrument Company limited, Huntingdon, England). Muscle sections of WT and 
mKO were collected onto the same uncoated glass slides and stored at -80°C 
until future analysis. Samples were thawed and fixed in an acetone:methanol 
(1:1) solution at -20°C then washed in PBS. Samples were permeabilised in a 
0.2% TritonX-100 solution for 10 minutes, then washed in PBS and followed by 
a 30 minute incubation in 5% normal goat serum (Invitrogen, UK) prepared in 
1% BSA. Samples were then incubated in p53 primary antibody (SCBT sc-
6243, rabbit, polyclonal; 1:20) prepared in 1% BSA overnight at 4°C. Slides 
were washed in PBS and incubated for 2 hours in goat anti rabbit IgG Alexa 
594 (ThermoFisher Scientific Inc. Waltham, MA, USA; 1:200) secondary 
antibody. Slides were then stained for dystrophin (DSHB, MANDYS1, mouse, 
monoclonal; 1:200) for 2 hours, washed in PBS and treated with goat anti 
mouse IgG2a Alexa 488 (ThermoFisher Scientific Inc. Waltham, MA, USA 
1:200) secondary antibody for 2 hours. Nuclei were labelled with 4',6-diamidino-
2-phenylindole (DAPI; 1:1000, Sigma-Aldrich, UK), prior to cover slipping with 
20µL Mowiol® 4-88 (Sigma-Aldrich, UK). Appropriate secondary antibody only 
control slides were used to ensure the specificity of the p53 antibody and that 
no apparent staining of dystrophin was visualized using the 540-580nm 
excitation filter in which p53 was detected. Slides were visualised using a Nikon 
E600 widefield microscope with a 40×0.75 numerical aperture objective. Images 
were captured under three colour filters using a SPOT RT KE colour three shot 
CCD camera (Diagnostic Instruments Inc., MI, USA), illuminated by a 170 W 
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Xenon light source. All images were captured using the same exposure time 
and gain for p53 staining in both WT and mKO muscle sections. A qualitative 
visual approach was used to indicate the presence or absence of p53. 
 
2.3.6 Enzyme activity assays 
Tissue was homogenised in a 10-fold mass excess of ice-cold sucrose muscle 
homogenisation buffer (24) by shaking in a FastPrep 24 5G (MP Biomedicals) 
at 6.0 m.s-1 for 80 s. Protein concentrations were determined by the DC protein 
assay (Bio-Rad, Hercules, California, USA). Gastrocnemius, quadriceps and 
triceps muscle were all analysed for maximal enzyme activity with data 
presented from triceps muscle. An equal volume of protein (10 µg for CS, 20 µg 
for β-HAD) was loaded onto 96-well microtiter plates in triplicate. For CS, 10 µL 
of sample was diluted in 235 µL of reaction buffer (64 mM TRIS pH 8.0, 0.13 
mM 5,5-dithio-bis-(2-nitrobenzoic acid), 0.13 mM acetyl CoA). 5 µL of 5 mM 
oxaloacetate was added to start the reaction and absorbance was read at 412 
nm for three minutes in a FLUOstar Omega microplate reader (BMG Labtech, 
Aylesbury, UK). For β-HAD, 15 µL of sample was diluted in 230 µL of reaction 
buffer (68 mM TRIS pH 8.0, 270 mM NADH, 270 mM EDTA, 270 mM Triton X-
100). 5 µL of 5 mM aceto-acetyl CoA was added to start the reaction and 
absorbance was read at 340 nm for 12 minutes. Enzyme activity in nmol.min-
1.mg-1 was determined from absorbance using the equation presented in 
Spinazzi et al (24) corrected for differences in pathlength. 
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2.3.7 Real time RT-qPCR 
RNA was extracted from quadriceps muscle by Tri reagent (Sigma Aldrich, 
Gillingham, UK) and purified on Reliaprep spin columns (Promega, Madison, 
Wisconsin, USA) using the manufacturers instructions. RNA concentrations 
were determined using the LVis function of the FLUOstar Omega microplate 
reader. RNA was diluted to 400 ng·µL-1 and reverse transcribed to cDNA using 
the RT2 First Strand kit (Qiagen, Manchester, UK). RT-qPCR analysis of mRNA 
content was performed in singleton by using custom designed 384-well RT2 
PCR Profiler Array (Qiagen) and RT2 SYBR Green Mastermix (Qiagen) on a 
CFX384 Real-Time PCR Detection System (Bio-Rad). 84 genes, plus reference 
genes, were analysed with 43 genes of interest selected a priori for analysis in 
this chapter. 2.8 ng of cDNA was added to each well. The absence of genomic 
DNA, the efficiency of reverse-transcription and the efficiency of the PCR assay 
were assessed on each plate and conformed to the manufacturers limits in 
each case. Relative mRNA expression was determined using the 2-∆∆CQ method 
(7) with the mean CQ value for the reference genes Gapdh, Actb, Hsp90ab1 
and B2m used as an internal control. Statistical analyses were performed on 
the ∆∆CQ data. 
 
2.3.8 Statistics 
Difference between genotypes was determined by independent t-tests using the 
Statistical Package for the Social Sciences (SPSS) version 22.0. Data are 
presented as means with 95% confidence intervals. Statistical significance was 
accepted as p ≤ 0.05. 
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2.4 Results 
2.4.1 Confirmation of p53 deletion in the p53 mKO mouse model 
In agreement with the previous characterisation of the p53 mKO model (5) we 
observed an ~70% reduction in Trp53 mRNA (Figure 2.1A), while an ~60% 
reduction in p53 protein content (Figure 2.1B) in skeletal muscle tissue from p53 
mKO mice was also apparent. Immunofluorescence staining of WT and mKO 
tibialis anterior muscle cross sections indicated an overall reduction in p53 
staining and a loss of p53-positive myonuclei (Figure 2.1C). However, non-
myofibrillar p53 staining was apparent in both WT and mKO muscle suggesting 
that the residual p53 apparent in immunoblots of mKO muscle likely reflects 
expression from non-muscle fibre cells resident within skeletal muscle tissue. 
 
2.4.2 Mitochondrial content and enzyme activity are maintained in 
p53 mKO 
Despite deletion of p53 in skeletal muscle fibres, the content of proteins within 
the electron transport chain were similar between p53 mKO and WT littermates 
(Figure 2.2A). Maximal activity of CS (Figure 2.2B), a strong correlate and 
validated surrogate of mitochondrial content (6), as well as Cyt-c and CS protein 
content (Figure 2.2A) were also maintained in p53 mKO mice. In addition, 
proteins involved in the regulation of mitochondrial fission (DRP1, FIS1) and 
fusion (MFN2, mitofillin, OPA1) were also unaffected by p53 mKO (Figure 2.3). 
Thus mitochondrial protein content and enzyme activity in skeletal muscle is 
maintained following muscle fibre-specific deletion of p53.  
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 Figure 2.1 Confirmation of p53 deletion in the p53 mKO mouse model 
Chapter 2: p53 and skeletal muscle mitochondrial biogenesis 
  101 
A. Reduction in Trp53 mRNA expression in quadriceps muscle of p53 mKO 
(grey squares) vs WT (black circles) mice (n = 3 - 4 per group). B. Reduction in 
p53 protein content in triceps muscle of p53 mKO mice (n = 4 per group). * p ≤ 
0.05 mKO vs WT; ** p ≤ 0.01 mKO vs WT. C. Representative 
immunofluorescence images for WT (left column) and mKO (right column) 
tibialis anterior muscle. The top row represents p53 only (red), the middle row 
shows a composite image of p53 (red), dystrophin (green) and dapi (blue), the 
bottom row shows an enlarged image of regions highlighted with a white box in 
the middle row. A reduction in overall staining can be seen in mKO compared to 
WT. Positive regions of p53 outside of the myofibre are apparent in both WT 
and mKO muscle and have been highlighted in dotted boxes in the third row. 
Myonuclei positive for p53 are apparent only in WT muscle and have been 
highlighted in yellow ovals in the third row. The scaling line in each image 
represents 50 µM. 
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Figure 2.2 Mitochondrial OXPHOS protein content and CS enzyme activity 
in p53 mKO and WT mice 
A. WT (black circles) and p53 mKO (grey squares) mice display similar protein 
content of mitochondrial enzymes (complexes I-V, CS and Cyt-c) in 
gastrocnemius muscle (p > 0.05; n = 6 per group). Similar data are apparent in 
triceps and quadriceps muscle (see appendices; Figure 6.1 &Figure 6.2). B. 
Similar maximal CS enzyme activity in triceps muscle of p53 mKO and WT mice 
(p > 0.05; n = 6-7 per group). Similar data are apparent in gastrocnemius and 
quadriceps muscle (see appendices;Figure 6.3). C. Representative immunoblot 
images. Data presented as means ± 95% confidence intervals. 
Chapter 2: p53 and skeletal muscle mitochondrial biogenesis 
  103 
Figure 2.3 Proteins controlling mitochondrial morphology are unchanged 
in p53 mKO compared to WT mice 
A. WT (black circles) and p53 mKO (grey squares) mice display similar content 
of proteins regulating mitochondrial fusion (MFN2, mitofillin, OPA1) and fission 
(DRP1 and FIS1) in gastrocnemius muscle (p > 0.05; n = 6 per group). Similar 
data are apparent in triceps and quadriceps muscle (see appendices; Figure 
6.1 & Figure 6.2). B. Representative immunoblot images. Data presented as 
means ± 95% confidence intervals. 
 
2.4.3 Loss of p53 does not alter regulators of substrate 
metabolism in skeletal muscle 
P53 mKO did not reduce the content of proteins involved in fatty acid transport 
and metabolism (ACADM, ACADL, ACADVL, β-HAD) or carbohydrate 
metabolism (HKII, PDH; Figure 2.4A). Furthermore, the maximal activity of the 
mitochondrial-localised fatty acid metabolic protein β-HAD was unaffected by 
p53 mKO (Figure 2.4B). 
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Figure 2.4 Abundance of fat and carbohydrate metabolism proteins are 
consistent between p53 mKO and WT mice 
A. WT (black circles) and p53 mKO (grey squares) mice display similar content 
of proteins involved in fatty acid (ACADM, ACADL, ACADVL and β-HAD) and 
carbohydrate (HKII and PDH) metabolism in gastrocnemius muscle (p > 0.05; n 
= 6 per group). Similar data are apparent in triceps and quadriceps muscle (see 
appendices; Figure 6.1 &Figure 6.2). B. Similar maximal β-HAD enzyme activity 
in triceps muscle of p53 mKO and WT mice (p > 0.05; n = 6-7 per group). 
Similar data are apparent in gastrocnemius and quadriceps muscle (see 
appendices;Figure 6.3). C. Representative immunoblot images. Data presented 
as means ± 95% confidence intervals. 
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2.4.4 Proteins controlling energy-sensing and mitochondrial gene 
expression are unaffected by p53 mKO 
Whole-body p53 KO mice exhibit reduced skeletal muscle mRNA and protein 
expression of TFAM (12) and protein content of PGC1α (18), while p53 has 
been implicated in the transcriptional control of AMPK subunits (4). Therefore 
we studied the protein content of PGC1α, TFAM, AMPKα, AMPKβ2 or NRF1 
within p53 mKO skeletal muscle. In contrast to whole-body p53 KO mice, p53 
mKO does not reduce the protein content of PGC1α, TFAM, AMPKα, AMPKβ2 
or NRF1 within skeletal muscle (Figure 2.5A) or the mRNA expression of 
PGC1α or TFAM (Figure 2.5B). 
 
2.4.5  Gene expression of proteins involved in skeletal muscle 
function and metabolism are unaltered by p53 mKO 
p53 mKO did not affect the mRNA expression of a sub-set of electron transport 
chain, mitochondrial morphology, mitochondrial transport, carbohydrate and 
fatty acid metabolism, transcription, angiogenic, or muscle development genes 
(Figure 2.6).  
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Figure 2.5 Protein content of mitochondrial biogenic signalling and 
transcriptional proteins in p53 mKO and WT mice 
A. The content of proteins regulating energy sensing (AMPKα, AMPKβ2), 
nuclear transcription (NRF1 and PGC1α) and mitochondrial transcription 
(TFAM) are similar in gastrocnemius muscle of WT (black circles) and p53 mKO 
(grey squares) mice (p > 0.05; n = 6 per group). Similar results were observed 
in triceps and quadriceps muscle (see appendices; Figure 6.1 &Figure 6.2). B. 
The mRNA expression of Pparg1a and Tfam are similar in quadriceps muscle 
of WT (black circles) and p53 mKO (grey squares) mice (p > 0.05; n = 4 per 
group). C. Representative immunoblot images. Data presented as means ± 
95% confidence intervals. 
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Figure 2.6 p53 mKO and WT mice display similar mRNA profiles 
p53 mKO and WT mice display similar mRNA expression of A. electron 
transport chain proteins and proteins involved in regulating B. mitochondrial 
morphology, C. mitochondrial protein transport, D. muscle development, E. 
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carbohydrate and fatty acid metabolism, F. transcription and G. angiogenesis. 
Each column represents the mRNA expression from the quadriceps muscle of a 
single mouse (p > 0.05; n = 4 per group).  
 
2.5 Discussion 
We report that muscle-specific deletion of p53 does not reduce mitochondrial 
protein content or enzyme activity within skeletal muscle. This is in contrast to 
previous research from whole-body p53 KO mice which reported a reduction in 
mitochondrial mass, mtDNA copy number, COX enzyme activity and state 3 
respiration (12, 18, 21). Given these discrepancies, we therefore interpret this 
data to indicate that the decrement in skeletal muscle mitochondrial function in 
whole-body p53 KO mice is a secondary consequence of an adverse 
phenotype of this mouse model, rather than due the loss of p53 per se in 
skeletal muscle fibres.  
 
p53 has been implicated in metabolic control within numerous cell types (1, 9, 
27). Indeed, p53 can exert direct or indirect transcriptional control over various 
metabolic and mitochondrial biogenic proteins in some cell types (e.g. PGC1α 
(18), TFAM (12, 18), cytochrome-c oxidase subunit 1 (CO1) (11), cytochrome-c 
assembly protein (SCO2) (9), AMPKβ (4), tp53-inducible glycolysis and 
apoptosis regulator (TIGAR) (1) and glucose transporter type 4 (GLUT4) (23)). 
However, our data indicates that in skeletal muscle, p53 is not required to 
maintain mitochondrial content and function. For example, the maximal activity 
of CS and the protein content of electron transport chain proteins were 
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maintained in p53 mKO mice. In addition, the content of proteins controlling 
mitochondrial morphology, substrate utilisation, energy sensing and 
transcription were comparable between p53 mKO and WT mice. The muscles 
examined within this study were, however, all predominantly made up of fast-
fibre types and it cannot be excluded that a different phenotype may be 
apparent in predominantly slow-fibre type muscles. Nonetheless, this data does 
indicate a normal metabolic phenotype of p53 mKO mice under basal 
conditions and is consistent with a similar skeletal muscle fibre-type distribution 
and diameter previously reported in p53 mKO mice (5).  
 
Unimpaired mitochondrial biogenesis in skeletal muscle of p53 mKO mice is in 
contrast to data published from whole-body p53 KO mice (12, 18, 21). Why 
whole-body p53 KO mice exhibit mitochondrial defects within skeletal muscle 
while p53 mKO mice do not is unclear. One explanation for the divergent 
phenotypes may be differences in the timing of p53 deletion in skeletal muscle 
between the two models. In the mKO mice examined here cre recombinase 
was expressed under the MCK promoter and as such p53 would not be deleted 
until ~13 days into embryonic development (8), whereas p53 is absent 
throughout the entirety of embryonic development in the germline deletion of 
the whole-body KO mice. Importantly, p53 is highly expressed in mouse 
embryos from embryonic day 8.5 to 10.5 (22). During myogenesis, p53 plays an 
important role in inducing differentiation (2, 14); a period of intense 
mitochondrial biogenesis (16). p53-/- myoblasts and C2C12 myoblasts treated 
with dominant-negative p53 inhibitors display impaired myosin heavy chain 
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induction during differentiation, potentially due to reduced expression of the 
muscle differentiation controlling proteins retinoblastoma protein (RB) and MCK 
(2, 14). Although direct evidence for a lack of mitochondrial development during 
differentiation in p53-/- myoblasts is lacking, mitochondrial deficits may arise in 
the whole-body KO mice due to a lack of p53 during this developmental period, 
while conversely p53 is expressed in skeletal muscle of the embryonic p53 
mKO mice during this stage. Additionally, a loss of p53 in satellite cells in 
whole-body KO mice may impair satellite cell differentiation into myocytes (14) 
during adulthood and therefore the continued regeneration and maintenance of 
healthy skeletal muscle (15). Thus the loss of p53 in one or multiple cell type(s) 
other than muscle fibres may contribute to a decrement in mitochondrial 
function within skeletal muscle.  
 
Several differences are also apparent in the expression of mitochondrial 
biogenic transcription factors/co-factors between the whole-body KO and mKO 
models. Park et al (12) demonstrated that p53 interacts with the TFAM gene in 
C2C12 myoblasts and that TFAM expression is reduced in the soleus muscle of 
whole-body p53 KO mice. Furthermore, PGC1α protein content was decreased 
in p53 KO mice examined by Saleem et al (18), although this contradicts similar 
PGC1α protein content found between WT and p53 KO mice by Park et al (12). 
In the p53 mKO mice studied here there were no deficits in TFAM or PGC1α 
protein or mRNA expression, which may explain the normal mitochondrial 
phenotype exhibited by p53 mKO mice. Alternatively, given the developmental 
nature of the mKO model, other regulators of mitochondrial biogenesis (13) may 
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be compensating for the loss of p53 in skeletal muscle, however exploration of 
all these pathways is outside the scope of this investigation. Thus an inducible 
muscle-specific knockout model is still required to determine whether p53 is 
important for maintaining mitochondrial function in mature skeletal muscle. 
 
Finally, the whole-body p53 KO mouse may not be a healthy model. Whole-
body p53 KO mice exhibit reduced voluntary wheel running (18), which if 
recapitulated as lower spontaneous physical activity in non-exercised mice may 
explain the reduced mitochondrial function. Furthermore, whole-body p53 KO 
mice develop spontaneous cancers at an early age (3), something that is often 
concomitant with cachexia and impaired muscle function. Nonetheless, utilising 
a muscle fibre-specific knockout model allows us, and others (17), to assess 
p53 function within skeletal muscle without the complications of potential 
secondary defects associated with loss of p53 in other cell types. 
 
While p53 within skeletal muscle fibres does not appear critical for developing 
or maintaining mitochondrial content within skeletal muscle of young healthy 
mice in the basal state, p53 does clearly play a role within skeletal muscle in 
other physiological contexts. For example, induction of p53 contributes to 
immobilisation-induced atrophy by orchestrating transcription of Cdkn1a/p21 
and possibly other genes that promote muscle fibre atrophy, whereas p53 mKO 
mice are protected from atrophy (5). p53 is also important in maintaining 
mitochondrial DNA stability and mediates exercise-induced mitochondrial 
biogenesis in PolG KO mice, a model of accelerated mitochondrial mutations 
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(17). Thus, it is likely that the importance of p53 may become apparent during 
ageing. Furthermore, it remains to be determined whether p53 mKO mice 
respond to endurance exercise training although whole-body p53 KO mice are 
uninhibited in this respect (18), which would indicate that p53 mKO would also 
be responsive to endurance exercise training. 
 
Our data indicates that muscle fibre-specific deletion of p53 does not impair 
mitochondrial protein content or enzyme activity in skeletal muscle. This is 
evidenced by similar content of proteins within the electron transport chain and 
proteins regulating mitochondrial morphology, substrate utilisation, energy 
sensing and transcription between WT and p53 mKO mice. In addition, there 
were no deficits in the maximal activity of the mitochondrial enzymes CS and β-
HAD in p53 mKO mice. While p53 likely has other roles in skeletal muscle 
physiology, from these data it does not appear that skeletal muscle p53 is 
necessary for developing or maintaining mitochondrial content in young healthy 
mice. 
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3.1 Abstract 
Exercise performed in the fasted state acutely increases fatty acid availability 
and utilisation. Furthermore, activation of energy-sensing pathways and fatty 
acid metabolic genes can be augmented by fasting and fasted exercise. 
However, whether a similar effect occurs at higher exercise intensities remains 
poorly understood. This study aimed to assess the effect of fed and fasted 
exercise upon post-exercise signalling and mRNA responses during moderate- 
to high-intensity steady-state exercise. Eight male participants (age: 25 ± 2 y, 
VO2peak: 47.9 ± 3.8 mL·kg-1·min-1) performed one hour of cycling at 70% Wmax in 
the fasted (FAST) state or two hours following ingestion of a carbohydrate-rich 
mixed-macronutrient breakfast (FED). Muscle biopsies were collected pre-, 
immediately and three-hours post-exercise from the medial vastus lateralis, 
whilst venous blood samples were collected throughout the trial. Plasma NEFA 
and glycerol concentrations were elevated during FAST compared to FED, 
although substrate utilisation during exercise was similar. AMPKThr172 
phosphorylation was elevated ~2.5-fold immediately post-exercise and was 
significantly augmented by ~1.2-1.4-fold during FAST. CREBSer133 
phosphorylation was also elevated by ~1.2-1.4-fold during FAST, although 
CREBSer133 phosphorylation was acutely decreased by ~60% immediately post-
exercise. SIRT1 and SIRT 3 activity, assessed by acetylation of p53Lys382 and 
MnSODLys122, respectively, were unchanged by fasting or acute exercise. 
PARP1 protein content decreased by ~25% post-exercise, whereas PARylation 
of PARP1 was unchanged. mRNA expression of PDK4 was augmented ~3-4-
fold by exercise and ~2-fold elevated throughout FAST, whilst expression of 
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PPARGC1A mRNA was similarly activated (~10-fold) by exercise in both FED 
and FAST. In summary, performing moderate- to high-intensity steady-state 
exercise in the fasted state increases systemic lipid availability, elevates 
phosphorylation of AMPKThr172 and CREBSer133, and augments PDK4 mRNA 
expression without corresponding increases in whole body fat oxidation and the 
mRNA expression of PPARGC1A. 
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3.2 Introduction 
During endurance exercise, transient perturbations in the cellular and 
extracellular milieu activate a number of intracellular signalling cascades 
thought to drive the initial adaptive response to exercise (20). Of note, the 
exercise-induced activation of AMP-activated protein kinase (AMPK), p38 
mitogen activated protein kinase (p38 MAPK), sirtuin 1 (SIRT1) and 
calcium/calmodulin dependent kinase II (CAMKII) are thought to be central to 
this response given they activate downstream transcription factors and 
transcriptional co-activators to initiate mitochondrial biogenesis (4, 5, 13, 19, 30, 
42, 71). With regularly repeated exercise bouts, transient upregulation of mRNA 
and subsequent protein translation manifest as cellular adaptations such as 
mitochondrial biogenesis (41). Given the associations between skeletal muscle 
mitochondrial function and the development of insulin resistance (33), the 
optimisation of the acute post-exercise adaptive response within skeletal 
muscle holds therapeutic potential.  
 
Performing exercise in the fasted state has the potential to produce favourable 
metabolic adaptations over and above fed exercise training (61). For example, 
moderate-intensity (50-75% VO2peak) exercise, performed in the fasted state, 
increases fatty acid availability and oxidation compared to exercise combined 
with carbohydrate ingestion (1, 10, 11, 15). At the cellular level, this response 
may be mediated in part via an AMPK-dependent mechanism, as skeletal 
muscle AMPKα2 activity is enhanced during moderate-intensity (60% Wmax) 
fasted exercise compared to glucose ingestion (1). Despite this, the optimal 
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integration of nutrition and exercise to augment adaptive signalling responses 
remains elusive. For example, AMPK and other exercise-sensitive signalling 
molecules can be further activated at more vigorous exercise intensities (e.g. 
~80% VO2peak) (19). However, it remains unclear whether this represents a 
maximal signalling response to moderate- to high-intensity steady-state 
exercise or whether superimposing fasting-induced nutritional stress can further 
enhance this. Furthermore, fasting per se activates additional exercise-sensitive 
signalling pathways within skeletal muscle including p38 MAPK (25), although 
this is not apparent in human skeletal muscle (17), SIRT1 (17) and cAMP 
response-element binding protein (CREB) (66), which remain to be studied in a 
fed versus fasted exercise model in humans. Thus the potential additive or 
synergistic effect of combining fasting with exercise on signalling pathways 
within human skeletal muscle remains incompletely understood.  
 
Therefore, the purpose of this study was to compare the effect of performing 
moderate- to high-intensity (70% Wmax) steady-state exercise in the fasted state 
or following the consumption of a mixed-macronutrient breakfast on post-
exercise signalling and mRNA expression in skeletal muscle. It was 
hypothesised that fasted exercise would result in an elevated peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A) and 
pyruvate dehydrogenase kinase 4 (PDK4) mRNA response over and above that 
induced by fed exercise and would be associated with augmented AMPKThr172 
and CREBSer133 phosphorylation and elevated SIRT1 and SIRT3 deacetylase 
activity. 
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3.3 Methods 
3.3.1 Participants 
Eight recreationally active males (mean ± SD: age, 25 ± 2 years; body mass, 
74.6 ± 5.2 kg; peak oxygen uptake (VO2peak), 47.9 ± 3.8 mL·kg-1·min-1; maximal 
aerobic power (Wmax), 272 ± 33 W) were recruited to participate. Required 
sample size was determined a priori based on the AMPKThr172 data from Guerra 
et al (26), which indicated that eight participants was required for α = 0.05 and 
1-β = 0.80. Participants were fully informed of the study procedures and their 
right to withdraw before providing written consent to participate. The study was 
approved by the National Health Service Research Ethics Committee, Black 
Country, West Midlands, UK. 
 
3.3.2 Pre-testing 
After measuring height (Seca 220, Seca, Birmingham, UK) and body mass 
(Champ II, OHAUS, Griefensee, Switzerland) participants performed a graded 
exercise test to exhaustion on a cycle ergometer (Lode Excalibur, Groningen, 
Netherlands). The test began with a five-minute warm-up at 100 W with power 
increasing by 35 W every three minutes thereafter. Respiratory variables were 
measured continuously during exercise using a breath-by-breath metabolic cart 
(Oxycon Pro, Jaeger, CareFusion, Germany), heart rate was monitored 
throughout (RCX5, Polar Electro Oy, Kempele, Finland) and ratings of 
perceived exertion (RPE) were determined using a 6-20 Borg scale during the 
final 15 seconds of each 3-minute stage (6). VO2peak was determined as the 
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highest rolling 30-second average and was stated as being achieved if the 
following criteria were met: i) heart rate within 10 beats·min-1 of age-predicted 
maximum and ii) respiratory exchange ratio (RER) > 1.1, or iii) plateau of 
oxygen consumption despite increasing work-rate. Wmax was determined as 
work rate at the last completed stage plus the fraction of time spent in the final 
non-completed stage multiplied by the increment in work rate (35W). 
 
3.3.3 Experimental trials 
Participants performed two experimental trials in a randomised, counter-
balanced, crossover design. By necessity of the design (i.e. food intake) it was 
not possible to blind participants or experimenters. Participants refrained from 
alcohol for 72 h, caffeine for 24 h and exercise for 48 h prior to each 
experimental trial. Prior to each experimental trial, participants were provided 
with a pre-prepared standardised three-day diet (energy contribution: 61% 
carbohydrate, 18% fat and 21% protein) matched to individual energy intake 
(mean ± SD: 2688 ± 450 kcal·day-1) determined by a three-day weighed food 
diary. 
 
Participants arrived at the laboratory at ~8 am following an ~12-hour overnight 
fast. Upon arrival, participants rested in the supine position for approximately 
ten minutes before a cannula was inserted into an antecubital forearm vein and 
a baseline venous blood sample was collected. Participants were then provided 
with a mixed-macronutrient breakfast (FED) (0.9 g·kg-1 body mass (BM) of corn 
flakes cereal, 3.9 mL·kg-1 BM of semi-skimmed milk, 1.1 g·kg-1 BM of toasted 
Nutrition and post-exercise energy-sensing in skeletal muscle 
  124 
wholemeal bread, 0.3 g·kg-1 BM of strawberry jam and 3.2 mL·kg-1 BM of 
orange juice (all Sainsbury’s, UK); energy intake: 710 ± 49 kcal; macronutrients: 
1.75 g·kg-1 BM carbohydrate (of which 0.66 g·kg-1 BM is sugar), 0.1 g·kg-1 BM 
fat and 0.35 g·kg-1 BM protein; energy contribution: 75% carbohydrate, 10% fat 
and 15% protein), which was consumed within the first 15 minutes of the trial, or 
participants remained in the fasted state (FAST). The macronutrient 
composition of the breakfast reflected population trends for relatively greater 
consumption of carbohydrates, and thus lower fat and protein ingestion, at 
breakfast time (2, 51, 68). Participants rested for two hours prior to providing a 
pre-exercise skeletal muscle biopsy from the medial vastus lateralis. 
Participants then cycled for one-hour at 70% Wmax before a second skeletal 
muscle biopsy was taken immediately post-exercise (completed within two 
minutes of exercise cessation). Participants then rested in a supine position 
prior to a third skeletal muscle biopsy being obtained three-hours post-exercise. 
In order to minimise discomfort for the participants the first two skeletal muscle 
biopsies (i.e., pre- and immediately post-exercise) were performed in the same 
leg with the third biopsy (i.e. 3-hours post-exercise) performed in the 
contralateral leg. The number of biopsies per leg was counterbalanced in the 
second trial and the leg receiving the initial biopsy was randomised. A new 
incision was made for each biopsy at least 2 cm from the previous site. Venous 
blood was collected throughout rest periods and during exercise. Respiratory 
variables were measured pre-exercise and at 15-minute intervals throughout 
exercise, heart rate was monitored continuously throughout exercise and RPE 
was determined at 15-minute intervals throughout exercise. Carbohydrate and 
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fat oxidation were calculated from VO2 and VCO2 using the moderate-high 
exercise intensities equation of Jeukendrup and Wallis (31) during exercise and 
Frayn (22) at rest. Participants drank water ad libitum during rest and exercise 
periods of trial one, with water intake matched during trial two to that consumed 
during each period of trial one (fluid intake during exercise: 618 ± 341 mL; post-
exercise fluid intake: 635 ± 343 mL). 
 
3.3.4 Muscle biopsies 
Muscle biopsies were obtained from separate incision sites on the medial 
vastus lateralis under local anaesthesia (1% lidocaine; B. Braun, Melsungen, 
Germany) by a Bergström needle adapted with suction. Muscle was rapidly 
blotted to remove excess blood and flash frozen in liquid nitrogen. Muscle was 
powdered using a Cellcrusher tissue pulveriser on dry ice and stored at -80°C 
prior to analysis. 
 
3.3.5 Immunoblotting 
Tissue was homogenised in a 10-fold mass excess of ice-cold sucrose lysis 
buffer (50 mM Tris, 1 mM EDTA, 1 mM EGTA, 50 mM NaF, 5 mM Na4P2O7-
10H2O, 270 mM sucrose, 1 M Triton-X, 25 mM β-glycerophosphate, 1 µM 
Trichostatin A, 10 mM Nicatinamide, 1mM 1,4-Dithiothreitol, 1% Phosphatase 
Inhibitor Cocktail 2; Sigma, 1% Sigma Phosphatase Inhibitor Cocktail 2; Sigma, 
4.8% cOmplete Mini Protease Inhibitor Cocktail; Roche) by shaking in a 
FastPrep 24 5G (MP Biomedicals) at 6.0 m·s-1 for 80 s and centrifuging at 4°C 
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and 8000 g for 10 minutes to remove insoluble material. Protein concentrations 
were determined by the DC protein assay (Bio-Rad, Hercules, California, USA). 
Samples were boiled at 97°C for 5 min in laemmli sample buffer and an equal 
volume of protein (20-50 µg) was separated by SDS-PAGE on 8 - 12.5% gels at 
a constant current of 23 mA per gel. Proteins were transferred on to BioTrace 
NT nitrocellulose membranes (Pall Life Sciences, Pensacola, Florida, USA) via 
wet transfer at 100 V for one hour. Membranes were then stained with Ponceau 
S (Sigma-Aldrich, Gillingham, UK) and imaged to check for even loading. 
Membranes were blocked in 3% dry-milk in tris-buffered saline with tween 
(TBST) for one hour before being incubated in primary antibody overnight at 
4°C. Membranes were washed in TBST three times prior to incubation in 
appropriate horse radish peroxidase (HRP)-conjugated secondary antibody at 
room temperature for one hour. Membranes were then washed in TBST three 
times prior to antibody detection via enhanced chemiluminescence HRP 
substrate detection kit (Millipore, Watford, UK). Imaging and band quantification 
were undertaken using a G:Box Chemi-XR5 (Syngene, Cambridge, UK). 
 
3.3.6 Antibodies 
All primary antibodies were used at a concentration of 1:1000 in TBST unless 
otherwise stated. Antibodies: acetylated proteins (ab193) and ac-MnSODK122 
(ab214675) were purchased from Abcam; AMPKα (2603), p-AMPKThr172 (2535), 
p-ACCSer79 (3661), CAMKII (3362), p-CAMKIIThr268 (12716), CREB (1°: 1:500; 
9197), p-CREBSer133 (1°: 1:500; 9191), p38 (9212), p-p38Thr180/Tyr182 (4511), poly 
ADP-ribose polymerase 1 (PARP1; 1°: 1:500; 9542), tumour protein 53 (p53; 
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2°: 1:2000; 2527) and ac-p53K382 (1°: 1:500 in 3% BSA, 2°: 1:2000; 2570) were 
purchased from Cell Signaling Technology; acetyl-CoA carboxylase (ACC; 05-
1098), superoxide dismutase (MnSOD; 1°:  1:2000; 06-984) and poly-ADP-
ribose (PAR; 1°: 1:500; MABE1031) were purchased from Merck Millipore. 
Secondary antibodies were used at a concentration of 1:10000 in TBST unless 
otherwise stated. Anti-rabbit (7074) and anti-mouse (7076) antibodies were 
from Cell Signaling Technology. 
 
3.3.7 Real time RT-qPCR 
RNA was extracted from ~20 mg of muscle by homogenising in 1 mL of Tri 
reagent (Sigma Aldrich, Gillingham, UK) using an IKA T10 basic ULTRA-
TURRAX homogeniser (IKA, Oxford, UK). Phase separation was achieved by 
addition of 200 µL of chloroform and centrifugation at 12000 g for 15 minutes. 
The RNA-containing supernatant was removed and mixed with an equal volume 
of 2-propanol. RNA was purified on Reliaprep spin columns (Promega, 
Madison, Wisconsin, USA) using the manufacturers instructions, which includes 
a DNase treatment step. RNA concentrations were determined using the LVis 
function of the FLUOstar Omega microplate reader (BMG Labtech, Aylesbury, 
UK). RNA was diluted to 30 ng·µL-1 and reverse transcribed to cDNA in 20 µL 
volumes using the nanoScript 2 RT kit and oligo(dT) primers (Primerdesign, 
Southampton, UK) as per the manufacturers instructions. RT-qPCR analysis of 
mRNA content was performed in triplicate by using Primerdesign custom 
designed primers for PPARGC1A (Accession number: NM_002612.3; Forward 
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primer: 5’-TTGCTAAACGACTCCGAGAAC-3’; Reverse primer: 5’-
GACCCAAACATCATACCCCAAT-3’), PDK4 (Accession number: NM_013261; 
Forward primer: 5’-GAGGGACACTCAGGACACTTTAC-3’; Reverse primer: 5’-
TGGAGGAAACAAGGGTTCACAC-3’) and commercially available GAPDH 
(Primerdesign) and Precision plus qPCR Mastermix with low ROX and SYBR  
(Primerdesign) on a QuantStudio3 Real-Time PCR System (Applied 
Biosystems, Thermo Fisher, UK). The qPCR reaction was run as per the 
manufacturers instructions (Primerdesign) and followed by a melt curve 
(Applied Biosystems) to ascertain specificity. 2-4 ng of cDNA was added to 
each well in a 20 µL reaction volume. qPCR results were analysed using 
Experiment Manager (Thermo Fisher). mRNA expression was expressed 
relative to the expression in the pre-exercise sample during FED for each 
individual using the 2-∆∆CQ method (36) with the Cq value for GAPDH used as an 
internal control. Statistical analysis was performed on the ∆∆CQ data. 
 
3.3.8 Blood analyses 
Blood samples were collected into tubes containing ethylenediaminetetraacetic 
acid (EDTA; BD, Oxford, UK) for the collection of plasma. Samples were placed 
immediately upon ice prior to centrifugation at 1600 g at 4°C for 10 minutes 
before collection of plasma from the supernatant. Plasma was frozen at -80°C 
until further analysis. Plasma samples were subsequently analysed on an 
autoanalyser (iLAB650, Instrumentation Laboratory, Bedford, MA, USA) for 
glucose, lactate, non-esterified fatty acid (NEFA) and glycerol (Randox 
Laboratories, County Antrim, UK) using commercially available kits. 
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3.3.9 Statistics 
Two-way repeated measures ANOVAs assessed effects of time, treatment and 
time*treatment interaction effects for all time-course data. Ryan-Holm-
Bonferroni multiple comparison corrections were applied post-hoc where 
applicable. Total area under the curve (tAUC) was determined for blood 
metabolites using the trapezoid method (37). Differences in tAUC for blood 
metabolites and means for exercising VO2, substrate utilisation, heart rate and 
RPE were assessed using repeated-measures t-tests. Due to issues with blood 
sampling from one participant, blood analyses are performed with a sample size 
of 7. All statistics were performed using the Statistical Package for the Social 
Sciences (SPSS) version 22.0. Data are presented as means with 95% 
confidence intervals. Statistical significance was accepted as p ≤ 0.05. 
 
3.4 Results 
3.4.1 Substrate availability and utilisation 
Plasma NEFA and glycerol concentrations were elevated during FAST (Figure 
3.1A & Figure 3.1B), indicative of elevated lipolysis and fatty acid availability. 
Plasma NEFA concentration displayed main effects for treatment (p = 0.004), 
time (p = 0.001) and a treatment*time interaction effect (p < 0.001). Plasma 
NEFA was significantly elevated in FAST compared to FED during exercise 
(135-165 minutes) and at twenty minutes into recovery (200 minutes; p < 0.05). 
tAUC for plasma NEFA across the experimental period was significantly 
elevated in FAST (p = 0.011). Plasma glycerol concentration showed main 
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effects for treatment (p = 0.007), time (p < 0.001) and a treatment*time 
interaction effect (p = 0.015). Plasma glycerol was significantly elevated during 
exercise (135-180 minutes) in FAST compared to FED (p < 0.05). tAUC for 
plasma glycerol across the experimental period was significantly higher in FAST 
(p = 0.006). Plasma glucose displayed a treatment*time interaction effect (p = 
0.024), whereby plasma glucose was higher in FAST immediately prior to 
exercise (120 minutes; Figure 3.1C). However, a lack of treatment effect (p = 
0.866) and no difference in tAUC (p = 0.942) shows plasma glucose was similar 
when the whole trial is considered. Plasma lactate displayed a significant effect 
for time (p < 0.001), increasing above baseline during exercise (135-180 
minutes) and remained so during the first 40 minutes of recovery (180-220 
minutes; p < 0.05; Figure 3.1D). No between-treatment differences were 
apparent for plasma lactate (main effect of treatment; p = 0.774, interaction; p = 
0.568, tAUC; p = 0.548). Carbohydrate and fat oxidation during exercise were 
similar between trials (Table 1). VCO2 was significantly lower during FAST 
exercise (p = 0.045). VO2, RER, heart rate and RPE did not differ during 
exercise between trials (Table 1). 
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Figure 3.1 Fasting augments NEFA and glycerol availability during 
endurance exercise 
Time-course and tAUC (inset) for plasma NEFA (A), glycerol (B), glucose (C) 
and lactate (D) in FED (black circles) and FAST (grey squares). Exercise (Ex) 
was performed between minutes 120 and 180. a: main effect of treatment (p ≤ 
0.05); b: main effect of time (significantly different to 0 minutes (pre-breakfast); 
p ≤ 0.05); c: interaction effect (significantly different between FED and FAST; p 
≤ 0.05). Data presented as means ± 95% confidence intervals (n = 7). 
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3.4.2 Skeletal muscle signalling 
Exercise increased the phosphorylation of AMPKThr172 (main effect of time; p < 
0.001); increasing ~2.5-fold immediately post-exercise (p < 0.001) and 
remaining ~1.5-fold above baseline three hours post-exercise (p < 0.001 vs pre-
exercise; Figure 3.2A). Furthermore, AMPKThr172 phosphorylation was elevated 
during the FAST trial (by ~20% and ~40% at pre- and immediately post-
exercise time points, respectively), displaying a main effect for treatment (p = 
0.050) and a trend towards a treatment*time interaction effect (p = 0.065). 
Phosphorylation of ACCSer79 (Figure 3.2B) increased ~7-fold immediately post-
exercise (p = 0.004 vs pre-exercise) and remained ~2-fold elevated 3-h post-
exercise (p = 0.016 vs pre-exercise, main effect of time; p = 0.002). Trends 
towards an effect of treatment (p = 0.092) and a treatment*time interaction 
effect (p = 0.071) were also apparent.  
 
FAST also induced an elevation in the phosphorylation of CREBSer133 (main 
effect of treatment; p = 0.050; Figure 3.2C). CREBSer133 phosphorylation also 
displayed a main effect for time (p = 0.003); decreasing in phosphorylation by 
~60% immediately post-exercise (p = 0.001). No treatment*time interaction 
effect was apparent (p = 0.667). 
 
Neither p38 MAPKThr180/Tyr182 (main effect of treatment; p = 0.315, time; p = 
0.208, interaction; p = 0.105) or CAMKIIThr286 (main effect of treatment; p = 
0.595, time; p = 0.751, interaction; p = 0.417) phosphorylation were significantly 
altered by exercise or feeding (Figure 3.2D & Figure 3.2E). 
Nutrition and post-exercise energy-sensing in skeletal muscle 
  134 
Figure 3.2 Fasting augments the phosphorylation of AMPKThr172 and 
CREBSer133  
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A. Phosphorylation of AMPKThr172 is increased post-exercise in each trial and is 
augmented during FAST. B. Phosphorylation of ACCSer79 is increased 
immediately post-exercise and remains elevated three hours post-exercise in 
each trial. C. CREBSer133 phosphorylation is augmented during FAST and 
decreases immediately post-exercise. D. p38 MAPKThr180/Tyr182 and E. 
CAMKIIThr286 remain unchanged throughout the intervention. F. Representative 
immunoblot images. Pre: pre-exercise; +0h: immediately post-exercise; +3h: 
three hours post-exercise. a: main effect of treatment (p ≤ 0.05); b: main effect 
of time (significantly different to pre-exercise; p ≤ 0.05). All values are presented 
relative to the group mean for all pre-FED samples. Data presented as means ± 
95% confidence intervals (n = 8). 
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Global acetylation within skeletal muscle was unaffected by fasting or exercise 
(main effect of treatment; p = 0.800, time; p = 0.300, interaction; p = 0.166; 
Figure 3.3A). Furthermore, the acetylation of p53Lys382, a SIRT1 deacetylation 
target (62), was unchanged in response to fasting or exercise (main effect of 
treatment; p = 0.950, time; p = 0.119, interaction; p = 0.242; Figure 3.3C). In 
addition, the acetylation of MnSODLys122, a SIRT3 deacetylation target (57), was 
unchanged by exercise or fasting as post-hoc analyses revealed no significant 
differences despite a significant treatment*time interaction effect (main effect of 
treatment; p = 0.578, time; p = 0.909, interaction; p = 0.024; Figure 3.3D). The 
protein content of PARP1 (Figure 3.4A), a NAD+-dependent enzyme that can 
supresses SIRT1 activity via competition for NAD+ (3, 38, 48), decreased by 
~25% immediately post-exercise (p = 0.029 vs pre-exercise) and remained 
lower three hours post-exercise (p = 0.034 vs pre-exercise, main effect of time; 
p = 0.003). There was no effect of fasting on PARP1 protein content (main 
effect of treatment; p = 0.629, interaction; p = 0.335). Despite a reduction in 
PARP1 protein content, the content of PARylated PARP1 was unchanged 
(main effect of treatment; p = 0.490, time; p = 0.776, interaction; p = 0.733; 
Figure 3.4B).  
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Figure 3.3 Fasting and exercise does not alter sirtuin deacetylase activity 
following endurance exercise 
A. Global acetylation within skeletal muscle is unaffected by fasting or exercise. 
B. Representative immunoblot images of global acetylation and Ponceau S 
stain. C. Acetylation of p53Lys382, a SIRT1 deacetylation site, is unchanged by 
fasting or endurance exercise. D. Acetylation of MnSODLys122, a SIRT3 
deacetylation site, is unchanged by fasting or endurance exercise. Pre: pre-
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exercise; +0h: immediately post-exercise; +3h: three hours post-exercise. b: 
main effect of time (significantly different to pre-exercise; p ≤ 0.05). All values 
are presented relative to the group mean for all pre-FED samples. Data 
presented as means ± 95% confidence intervals (n = 8). 
Figure 3.4 Endurance exercise decreases PARP1 protein content, however 
PARylation is unchanged 
A. Protein content of PARP1 is decreased immediately post-exercise and 
remains decreased three hours post-exercise. B. Auto-PARylation of PARP1 is 
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unaffected by fasting or exercise. C. Representative immunoblot images of 
PARylation and Ponceau S stain. Pre: pre-exercise; +0h: immediately post-
exercise; +3h: three hours post-exercise. b: main effect of time (significantly 
different to pre-exercise; p ≤ 0.05). All values are presented relative to the group 
mean for all pre-FED samples. Data presented as means ± 95% confidence 
intervals (n = 8). 
 
3.4.1 Metabolic mRNA response 
PPARGC1A mRNA expression increased ~10-fold three hours after exercise 
(main effect of time; p < 0.000; p < 0.001 vs pre-exercise; Figure 3.5A). 
PPARGC1A mRNA expression was similar in FED and FAST trials (main effect 
of treatment; p = 0.863, interaction; p = 0.540). 
 
Expression of PDK4 increased with time (main effect of time; p < 0.001) and 
was elevated by ~2-3.5-fold throughout the FAST trial (main effect of treatment; 
p = 0.001, Figure 3.5B). There was a trend for a treatment*time interaction 
effect (p = 0.083), whereby at the immediately post-exercise time point PDK4 
expression increased ~2-fold from pre-exercise values only in the FAST trial 
(FAST immediately post-exercise vs FAST pre-exercise; p = 0.031, FED 
immediately post-exercise vs FED pre-exercise, p = 0.950).  
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Figure 3.5 Fasting augments PDK4 mRNA expression, however exercise-
induced PPARGC1A mRNA expression is similar in fed and fasted states 
A. Resting and exercise-induced PPARGC1A mRNA expression is similar 
between FED and FAST trials. B. PDK4 mRNA expression is augmented during 
FAST. Pre: pre-exercise; +0h: immediately post-exercise; +3h: three hours 
post-exercise. a: main effect of treatment (p ≤ 0.05);  b: main effect of time 
(significantly different to pre-exercise; p ≤ 0.05). All values are presented 
relative to the individual pre-FED value using the 2-∆∆CQ method. Data presented 
as means ± 95% confidence intervals (n = 8). 
 
3.5 Discussion 
Our results build on previous studies (1, 10, 11, 26) to demonstrate that 
moderate- to high-intensity steady-state endurance exercise (70% Wmax) 
performed in the fasted state increases fatty acid availability, augments 
AMPKThr172 phosphorylation and increases PDK4 mRNA expression compared 
to exercise performed following the ingestion of a standard breakfast. 
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Furthermore, while endurance exercise acutely decreased phosphorylation of 
CREBSer133, fasting increased the phosphorylation of this activation site. 
However, despite elevated phosphorylation of AMPK and the transcription 
factor CREB during fasted exercise, the exercise-induced increases in ACCSer79 
phosphorylation, PPARGC1A mRNA and whole-body fat oxidation were similar 
between treatments. 
 
FAST elevated AMPKThr172 phosphorylation throughout the experimental period. 
Furthermore, a trend (p = 0.065) towards an interaction effect indicates that the 
exercise-activated AMPKThr172 phosphorylation was likely augmented during 
fasted exercise. This supports previous research finding elevated AMPKα 
activity or AMPKThr172 phosphorylation following single-legged moderate-
intensity (60% Wmax) or sprint exercise performed in the fasted state compared 
to when glucose is consumed (1, 26). However, this is not a universal finding. 
Similar post-exercise AMPKThr172 phosphorylation following fed and fasted 
exercise has also been reported (1, 15, 35, 52, 60), while elevated AMPKThr172 
phosphorylation following fed exercise can also be apparent (18). It is unclear 
why these differences in the literature occur, although some of the 
discrepancies may be due to the amount of carbohydrate ingested in each 
study. For example, the breakfast provided in the study of Edinburgh et al (18), 
where AMPKThr172 phosphorylationwas augmented in the fed state, included 
only 65g of carbohydrate. However, the total carbohydrate ingestion in the 
current study (~130 g) was similar to studies that have demonstrated no effect 
of fasting on exercise-induced AMPKThr172 phosphorylation (1, 35), although the 
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pattern of ingestion did differ (i.e. one large dose pre-exercise versus several 
smaller doses throughout exercise, respectively). Ingestion of a carbohydrate-
rich breakfast, albeit one providing more carbohydrate than in the current study, 
can increase skeletal muscle glycogen content within several hours (9). Thus in 
the current study, unlike when carbohydrate drinks are provided throughout 
exercise, exercise may have been commenced with differing levels of skeletal 
muscle glycogen, which has the potential to influence AMPK phosphorylation 
and activity within skeletal muscle (5, 34, 43, 55, 70, 72). Furthermore, elevated 
AMPKThr172 phosphorylation during FAST could be a result of increased 
allosteric activation by AMP (16, 25, 39, 69). Indeed, skeletal muscle AMP and 
the AMP/ATP ratio is elevated during exercise performed in the fasted 
compared to the fed state (35). Nonetheless, it remains inconclusive as to why 
AMPK phosphorylation is likely enhanced during FAST in the present study. 
 
Consistent with previous literature, fasting and fasted exercise augmented the 
expression of PDK4 mRNA (10, 11, 17, 46, 54, 66, 67). However, conversely to 
continuous glucose ingestion throughout exercise and recovery (10, 11), 
ingestion of a standard carbohydrate-rich breakfast two-hours prior to exercise 
did not completely ablate the exercise-induced expression of PDK4 mRNA. 
Given that the total carbohydrate and energy intake were similar between this 
study and those of Civitarese et al (10) and Cluberton et al (11), this suggests 
that the timing and frequency of ingestion and/or the type of carbohydrate 
ingested (i.e. complex starches versus simple sugars) may be important in the 
regulation of PDK4 mRNA expression. Substrate availability is known to play an 
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important role in skeletal muscle PDK4 mRNA expression (45). In the current 
study, elevated NEFA availability during FAST may explain activation of PDK4 
mRNA immediately post-exercise (i.e. during exercise) in the FAST trial only. 
Furthermore, elevating circulating NEFA post-exercise in both trials could 
explain why PDK4 mRNA expression is elevated post-exercise following fed 
exercise in the current study and not when NEFA remains suppressed by 
continued carbohydrate supplementation (10, 11). Mechanistically, augmented 
PDK4 mRNA expression during FAST may be mediated by elevated PPARα 
activation known to be responsive to exercise, NEFA concentration and energy-
stress (40, 44). 
 
Elevated activation of AMPK and PDK4 during fasting has the potential to 
acutely influence substrate metabolism. AMPK phosphorylates ACC thereby 
increasing fatty acid oxidation (27), while PDK4 phosphorylates PDH-E1α, 
inactivating the pyruvate dehydrogenase complex (PDC), and thereby inhibiting 
the decarboxylation of pyruvate to acetyl-CoA and, thus, carbohydrate oxidation 
(47). However, substrate utilisation during exercise was similar between FED 
and FAST, despite elevated NEFA availability during FAST. This is likely due to 
the intensity of exercise dictating reliance upon carbohydrate oxidation and a 
sufficient endogenous supply of carbohydrate, i.e. muscle and liver glycogen, in 
the FAST trial. Indeed, plasma glucose concentration was unaffected by FAST, 
while phosphorylation of ACCSer79 was also similar between treatments. Despite 
this, it cannot be ruled out that differences in substrate oxidation may arise if the 
exercise duration was extended, although this would likely require a reduction in 
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exercise intensity. Overall this supports findings from a recent meta-analysis in 
which it was determined that fat oxidation was similar between fed and fasted 
aerobic exercise performed above 70% VO2max (63). Nonetheless, elevated 
plasma NEFA and glycerol concentrations, despite similar rates of fat oxidation, 
indicate that increased lipolysis during fasted exercise is determined at the 
adipose tissue, independently of demand from the exercising musculature. In 
this respect, fasted exercise upregulates the expression of lipolytic genes 
adipose triglyceride lipase (PNPLA2) and hormone sensitive lipase (LIPE) in 
adipose tissue of overweight males (8).  
 
Metabolic adaptations within skeletal muscle are regulated by transcription 
factors and co-factors, including CREB and PGC1α. Elevated phosphorylation 
of CREBSer133, purported to increase the transcriptional activity of CREB (23), 
has been reported within skeletal muscle in the context of fasting (66) and 
exercise (19, 49). Thus it was examined here whether an additive or synergistic 
effect of fasted exercise may be apparent on CREBSer133 phosphorylation. 
Compared to FED, CREBSer133 phosphorylation was elevated throughout the 
trial during FAST. Whilst, similarly as reported by Egan et al (19), exercise 
reduced phosphorylation of CREBSer133 immediately post-exercise and tended 
to increase above baseline levels by three-hours post-exercise. However, this is 
certainly not a universal finding with increased CREBSer133 phosphorylation (49) 
or no change in phosphorylation (64, 65) also apparent immediately post-
exercise. This variation in results could be due to methodological differences in 
exercise modality and intensity; CREBSer133 phosphorylation decreases to a 
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larger extent following cycling at 80% VO2peak compared to at 40% VO2peak (19). 
Furthermore, the metabolic stress induced from single-legged exercise (64, 65) 
and two-legged cycling (19, 49) is likely to be different. Interestingly, during 
unilateral exercise CREBSer133 phosphorylation can be elevated in the non-
exercising contralateral leg whilst remaining unchanged in the exercising leg 
(64). This suggests that while exercise-induced systemic factors may activate 
skeletal muscle CREB, local contraction-mediated factors may oppose this and 
even cause dephosphorylation if the intensity is sufficient (19). Circulating 
catecholamines, which are elevated during fasting and exercise (15), induce 
cellular cAMP accumulation and activate PKA (28, 50), the upstream kinase of 
CREB. CREB can also be phosphorylated by AMPK (59), CAMKII (53) and p38 
MAPK (56), however differing time-courses of AMPK and CREB 
phosphorylation and a lack of activation of CAMKII and p38 MAPK in this study 
suggest other kinases are responsible for post-exercise CREBSer133 
phosphorylation. CREB can be dephosphorylated by calcineurin, PP1, PP2A 
(21) and PTEN (24), although how dephosphorylation of CREB is regulated 
within skeletal muscle remains unknown. Calcineurin is activated by Ca2+ influx 
(14) and is therefore an attractive candidate to explain CREB 
dephosphorylation during exercise. Conversely, the activity of PP1 may 
decrease during contraction (32). Overall it remains unclear why CREBSer133 
phosphorylation may decrease during exercise. 
 
Endurance exercise did not alter the activity of the NAD+-dependent 
deacetylase SIRT1, as measured by the acetylation of p53Lys382 (62). This is in 
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contrast to evidence in rodent models of exercise whereby SIRT1-mediated 
deacetylation of p53 is apparent (42). Furthermore, 12 hours of fasting was 
insufficient to induce p53Lys382 deacetylation. Indeed, 48 hours of fasting only 
reduces p53 Lys382 acetylation by ~15% (17), thus it appears that substantial 
energy stress is required to alter SIRT1 activity and p53 acetylation within 
human skeletal muscle. Comparatively, neither fasting nor exercise altered 
SIRT3 activity, as measured by the acetylation of MnSODLys122 (57). This 
corroborates previous evidence showing SIRT3 is unaffected by single-legged 
endurance exercise performed in the fasted state (7). As a NAD+-consumer, 
PARP1 activity may be opposing activation of SIRT1 (3, 38, 48). Indeed, 
PARP1 inhibition augments NAD+ concentrations, PGC1α deacetylation and 
mitochondrial biogenesis in response to skeletal muscle contraction (38). Thus, 
we examined the effects of exercise on PARP1 protein content and PARP 
activity. One hour of 70% Wmax cycling decreased PARP1 protein content within 
skeletal muscle. A decrease in PARP1 protein content following high-intensity 
interval exercise (5 x 2 minutes at 80% Wmax) has previously been reported in 
elderly participants, although high intensity interval exercise actually increased 
PARP1 protein content in young untrained participants (12). The difference in 
PARP1 response to high-intensity interval training and moderate- to high-
intensity steady state exercise in young participants could reflect differences in 
the cellular stress between the two protocols. Despite decreased content of 
PARP1, no change in auto-PARylation of PARP1, a measure of PARP1 activity 
(58), was apparent following fasting or exercise. Thus PARP1 activity, and 
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presumably PARP1-mediated NAD+-consumption, was unaffected by 
endurance exercise. 
 
Despite elevated phosphorylation of the upstream kinase AMPK and 
transcription factor CREB, PPARGC1A mRNA expression was similar between 
FED and FAST. This corroborates previous data finding similar PPARGC1A 
mRNA expression following exercise performed in the fasted versus glucose-
supplemented state (10, 11). Interestingly, this differs from the glycogen-
depleted state, where basal and exercise-induced PPARGC1A mRNA 
expression is augmented (5). This indicates that greater metabolic stress is 
apparent during glycogen-depleted exercise rather than fasting and fasted-
exercise. As PPARGC1A mRNA expression is, to a degree, self-regulated (29) 
these data indicate that PGC1α co-transcriptional activity may be similar when 
exercise is performed in the fed or fasted states. It is intriguing that this is the 
case despite elevated AMPK and CREB phosphorylation in the fasted state. It 
could be speculated that the degree of additional AMPK and CREB 
phosphorylation in FAST is not large enough to augment PPARGC1A mRNA 
expression. Another explanation may be that PGC1α integrates a large number 
of signals from many converging pathways and as such differential activation of 
the AMPK pathway without activation of other pathways, e.g. p38 MAPK, 
CAMKII and SIRT1, is insufficient to alter PGC1α co-transcriptional activity.  
 
Overall, fasting and fasted exercise augments the phosphorylation of 
AMPKThr172 and the mRNA expression of PDK4 within human skeletal muscle. 
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Furthermore, fasting increases the phosphorylation of CREBSer133, although 
CREBSer133 phosphorylation is acutely decreased during exercise. However, 
PPARGC1A mRNA expression is similar between fed and fasted skeletal 
muscle in the resting and exercised states. Thus while fasting increases the 
systemic availability of NEFAs and the expression of genes associated with 
fatty acid metabolism, greater energy stress is required to augment the 
expression of the mitochondrial biogenic regulator PPARGC1A. 
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4.1 Abstract 
Rodent studies have indicated that oral nicotinamide riboside (NR) 
supplementation can induce sirtuin (SIRT) signalling and mitochondrial 
biogenesis in skeletal muscle. Furthermore, the safety of NR supplementation 
has been demonstrated in humans. This study aimed to assess the effect of NR 
supplementation on resting and exercise-induced sirtuin signalling and 
peroxisome proliferator-activated receptor gamma coactivator 1-alpha 
(PPARGC1A) mRNA expression, as well as substrate utilisation in humans. In a 
double-blinded, randomised, counter-balanced, crossover design, eight male 
participants (age: 23 ± 4 years, VO2peak: 46.5 ± 4.4 mL·kg-1·min-1) received one 
week of NR or cellulose placebo (PLA) supplementation (1000 mg·d-1) before 
performing one hour of cycling at 60% Wmax. Muscle biopsies were collected 
prior to supplementation and pre-, immediately and three-hours post-exercise  
from the medial vastus lateralis, whilst venous blood samples were collected 
throughout the trial. Global acetylation and acetylation of p53Lys382, a SIRT1 
target, and MnSODLys122, a SIRT3 deacetylation was unaffected by NR 
supplementation or exercise. Furthermore, exercise led to an induction of 
PPARGC1A (~5-fold) and PDK4 (~10-fold) mRNA expression but NR had no 
effect on this response. There was also no effect of NR supplementation on 
substrate utilisation at rest or during exercise or on skeletal muscle 
mitochondrial respiration. However, NR supplementation blunted the exercise-
induced activation of skeletal muscle NNMT mRNA expression, whereas the 
mRNA expression of other enzymes involved in NAD+ metabolism (NMRK1, 
NAMPT, NMNAT1) were not significantly affected by NR supplementation or 
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exercise. In summary, one week of NR supplementation at 1000 mg·d-1 does 
not augment sirtuin signalling, PPARGC1A mRNA expression or metabolism at 
rest or during exercise. However, NR supplementation did impair the exercise-
induced activation of NNMT mRNA within skeletal muscle. 
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4.2 Introduction 
Nicotinamide adenine dinucleotide (NAD+), including its reduced form NADH, is 
a redox co-enzyme that shuttles hydride ions between processes of fuel 
oxidation, as well as within biosynthethic pathways (40). In addition to central 
roles in these critical metabolic processes, NAD+ has emerged as a signalling 
moiety and an obligatory co-substrate for sirtuins (SIRTs), poly ADP-ribose 
polymerases (PARPs) and cyclic ADP-ribose synthetases (3). Thus NAD+ is an 
important substrate in pathways governing metabolic adaptations, DNA repair 
and apoptosis, among others (3, 40). Given the regulatory role of NAD+ in 
lifespan extending processes, it is unsurprising that strategies to elevate cellular 
NAD+ are considered as promising therapies. Indeed, elevating cellular NAD+ in 
vivo leads to positive outcomes in murine models of diabetes (28, 41), ageing 
(9, 26, 28), obesity (5), vascular dysfunction (9), muscular dystrophy (29) and 
Alzheimer’s disease (24).  
 
The vitamin B3 molecule nicotinamide riboside (NR) has emerged as one 
strategy to elevate NAD+ in vivo. In rodents, oral NR supplementation increases 
fat oxidation (at least during the dark, inactive phase) (5), promotes metabolic 
flexibility (30), improves insulin sensitivity and may improve endurance 
performance (5), although a trend towards impaired endurance performance 
has also been noted (20). Mechanistically, in vitro and in vivo, NR 
supplementation increases SIRT1 and SIRT3 activities, deacetylation of 
peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) 
and induces mitochondrial biogenesis (5, 6, 19, 29). Interestingly, and 
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somewhat unsurprisingly, the effects of NR supplementation are much more 
pronounced during models of elevated cellular (and thus NAD+) stress (5, 6, 14, 
19, 29). Furthermore, genetically elevating myocellular NAD+, via muscle-
specific overexpression of nicotinamide phosphoribosyltransferase (NAMPT) in 
young healthy mice, only augments markers of mitochondrial biogenesis when 
coupled with endurance exercise training (8, 14). Thus, herein, the effect of NR 
supplementation on cellular signalling in humans is studied in the context of 
acute endurance exercise, where fluctuation of NAD+/NADH and NAD+-
consumption have been reported (38). 
 
Studies investigating NR supplementation in humans are in their infancy (1, 10, 
11, 25, 34). Importantly, the safety and bioavailability of NR has been 
demonstrated in humans (10, 11, 25, 34), with NR supplementation reported to 
improve blood pressure (25), liver health (10) and physical function in the 
elderly (10), although the latter is not a consistent finding (25). However, 
despite promising evidence from pre-clinical models (5, 30), no effect of chronic 
NR supplementation on insulin sensitivity, body composition, lipolysis, VO2peak 
and resting or exercising substrate utilisation is apparent (11, 25). The effect of 
NR on skeletal muscle signalling at rest and during exercise remains unstudied. 
 
The purpose of this study was to investigate the effects of oral NR 
supplementation on mitochondrial biogenic signalling and mRNA expression in 
resting and exercising human skeletal muscle. Furthermore, the effect of NR 
supplementation on substrate utilisation at rest and during exercise was also 
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examined. It was hypothesised that NR supplementation would elevate SIRT1 
and SIRT3 signalling and increase the exercise-induced expression of 





Eight recreationally active males (mean ± SD: age, 23 ± 4 years; body mass, 
72.4 ± 5.3 kg; peak oxygen uptake (VO2peak), 46.5 ± 4.4 mL·kg-1·min-1; maximal 
aerobic power (Wmax), 224 ± 29 W) were recruited to participate. Participants 
were fully informed of the study procedures and their right to withdraw before 
providing written consent to participate. The study was pre-approved by the 
National Health Service Research Ethics Committee, Black Country, West 
Midlands, UK (17/WM/0321). 
 
4.3.2 Experimental overview 
Participants attended the laboratory on five occasions. Prior to the experimental 
periods, participants attended the laboratory for a pre-testing visit to determine 
VO2peak and Wmax. The experimental period then consisted of two identical 
experimental blocks in which participants visited the laboratory before and after 
a seven-day supplementation period. During the supplementation period 
participants received either 1000 mg·d-1 nicotinamide riboside (NR; Niagen, 
ChromaDex, Irvine CA, USA) or 1000 mg·d-1 of a cellulose placebo (PLA) in a 
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double-blinded, randomised, counter-balanced, crossover design. Supplements 
were consumed twice daily such that participants were instructed to consume 
500 mg of supplement at ~9 am and ~9 pm each day. A two-week washout 
period was employed between experimental blocks. 
 
4.3.3 Pre-testing 
After measuring height (Seca 220, Seca, Birmingham, UK) and body mass 
(Champ II, OHAUS, Griefensee, Switzerland) participants performed a graded 
exercise test to exhaustion on a cycle ergometer (Lode Excalibur, Groningen, 
Netherlands). The test began at 50 W with power increasing by 25 W every 
three minutes thereafter. Respiratory variables were measured continuously 
during exercise using a breath-by-breath metabolic cart (Vyntus CPX, Jaeger, 
CareFusion, Germany), heart rate was monitored throughout (RCX5, Polar 
Electro Oy, Kempele, Finland) and ratings of perceived exertion (RPE) were 
determined using a 6-20 Borg scale during the final 15 seconds of each 3-
minute stage (4). VO2peak was determined as the highest rolling 30-second 
average and was stated as being achieved if the following criteria were met: i) 
heart rate within 10 beats·min-1 of age-predicted maximum and ii) respiratory 
exchange ratio (RER) > 1.1, or iii) plateau of oxygen consumption despite 
increasing work-rate. Wmax was determined as work rate at the last completed 
stage plus the fraction of time spent in the final non-completed stage multiplied 
by the increment in work rate (25W). 
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4.3.4 Experimental trials 
Participants refrained from alcohol for 72 h, caffeine for 24 h and exercise for 48 
h prior to each experimental trial. For 72 h prior to each experimental trial 
participants consumed a replicated diet. For the first 48 h of this period 
participants consumed a diet that replicated their ad libitum intake recorded via 
a weighed food diary prior to the first experimental visit. For the final 24 h prior 
to each experimental visit participants were provided with a standardised diet 
(energy: 2271 kcal; macronutrient composition: 63% carbohydrate, 21% fat and 
16% protein).  
 
For the pre-supplementation visit, participants arrived at the laboratory at ~8:30 
am following an ~12-hour overnight fast. Upon arrival, participants rested in the 
supine position for approximately five minutes before a venous blood sample 
was collected via venepuncture from an antecubital forearm vein. A resting 
skeletal muscle biopsy was then taken from the medial vastus lateralis. 
Participants then consumed the first 500 mg dose of their supplement prior to 
leaving the laboratory. 
 
For the post-supplementation visit, participants arrived at the laboratory at 
~7:30 am following an ~12-hour overnight fast. Participants rested in the supine 
position for ten minutes prior to a 20-minute measurement of resting metabolic 
rate under a ventilated hood using the GEMNutrition indirect calorimeter 
(GEMNutrition, Daresbury, UK). A cannula was then inserted into an antecubital 
forearm vein and a baseline venous blood sample was collected prior to 
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providing a pre-exercise skeletal muscle biopsy from the medial vastus lateralis. 
Participants then cycled for one-hour at 60% Wmax before a second skeletal 
muscle biopsy was taken immediately post-exercise (completed within two 
minutes of exercise cessation). Participants then rested in a supine position 
prior to a third skeletal muscle biopsy being obtained three-hours post-exercise. 
A new incision was made for each biopsy at least 2 cm from the previous site. 
Venous blood was collected throughout rest periods and during exercise. 
Respiratory variables were measured pre-exercise and at 15-minute intervals 
throughout exercise, heart rate was monitored continuously throughout exercise 
and RPE was determined at 15-minute intervals throughout exercise. 
Carbohydrate and fat oxidation were calculated from VO2 and VCO2 using the 
moderate-high exercise intensities equation of Jeukendrup and Wallis (18) 
during exercise and Frayn (13) at rest. Participants were allowed to drink water 
ad libitum during rest and exercise periods during the visit following the first 
supplementation period, with water intake during the visit following the second 
supplementation period matched to the first. 
 
4.3.5 Muscle biopsies 
Muscle biopsies were obtained from separate incision sites on the medial 
vastus lateralis under local anaesthesia (1% lidocaine; B. Braun, Melsungen, 
Germany) by a Bergström needle adapted with suction. Muscle was rapidly 
blotted to remove excess blood and was immediately flash frozen in liquid 
nitrogen. In the case of pre-supplementation and pre-exercise biopsies, an ~20 
mg section was removed prior to freezing and placed in ice-cold BIOPS buffer 
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(2.77 mM CaK2EGTA, 7.23 mM K2EGTA, 5.77 mM Na2ATP, 6.56 mM MgCl2, 
20 mM taurine, 15 mM Na2Phosphocreatine, 20 mM imidazole, 0.5 mM DTT, 
and 50 mM MES) for the immediate measurement of mitochondrial respiration. 
Frozen muscle was powdered using a Cellcrusher tissue pulverizer on dry ice 
and stored at -80°C prior to analysis. 
 
4.3.6 High-resolution respirometry 
Skeletal muscle fibres were mechanically separated under a light microscope 
and permeabilised by incubation in BIOPS buffer containing 50 mg·ml-1 of 
saponin for 30 minutes followed by a 15-minute wash in MiR05 buffer (0.5 mM 
EGTA, 3 mM MgCl2·6H2O, 60 mM K-lactobionate, 20 mM taurine, 10 mM 
KH2PO4, 20 mM HEPES, 110 mM sucrose, and 1 g·L
-1 fatty acid-free bovine 
serum albumin). Samples were then weighed and analysed in duplicate using 
an Oroboros O2K (Oroboros Instruments, Innsbruck, Austria). When substantial 
variability was apparent between duplicates a third sample was run. Data was 
collected at 37°C in hyperoxygenated (200-400 mM) conditions in MiR05 buffer. 
The substrate-uncoupler-inhibitor titration performed was as follows: 5 mM 
pyruvate, 2 mM malate, and 10 mM glutamate was added to measure leak 
respiration through complex one (CIL); 5 mM ADP was then added to measure 
coupled oxidative phosphorylation through complex one (CIP); 10 mM succinate 
was then added to measure coupled oxidative phosphorylation through 
complexes one and two (CI+IIP); 10 µM cytochrome-c was added to test outer 
mitochondrial membrane integrity; titrations of 0.5 µM FCCP until maximal 
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respiration were then added to measure maximal electron transport chain 
capacity (CI+IIE); 5 µM antimycin A was then added to measure non-
mitochondrial respiration. Respiration was normalised to tissue masses and 
non-mitochondrial respiration was subtracted to give mass-specific 
mitochondrial respiration. In all samples the increase in respiration following 




Tissue was homogenized in a 10-fold mass excess of ice-cold sucrose lysis 
buffer (50 mM tris, 1 mM EDTA, 1 mM EGTA, 50 mM NaF, 5 mM Na4P2O7-
10H2O, 270 mM sucrose, 1 M triton-X, 25 mM β-glycerophosphate, 1 µM 
trichostatin A, 10 mM nicatinamide, 1mM 1,4-dithiothreitol, 1% phosphatase 
inhibitor Cocktail 2; Sigma, 1% phosphatase inhibitor cocktail 2; Sigma, 4.8% 
cOmplete mini protease inhibitor cocktail; Roche) using an IKA T10 basic 
ULTRA-TURRAX homogeniser (IKA, Oxford, UK) followed by shaking at 4°C for 
30 minutes and centrifuging at 4°C and 8000 g for 10 minutes to remove 
insoluble material. Protein concentrations were determined by the DC protein 
assay (Bio-Rad, Hercules, California, USA). Samples were prepared in laemmli 
sample buffer, boiled at 97°C for 5 min (with the exception of an aliquot set 
aside for determination of electron transport chain protein content which 
remained unboiled) and an equal volume of protein (18-36 µg) was separated 
by SDS-PAGE on 8 - 12.5% gels at a constant current of 23 mA per gel. 
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Proteins were transferred on to BioTrace NT nitrocellulose membranes (Pall 
Life Sciences, Pensacola, Florida, USA) via wet transfer at 100 V for one hour. 
Membranes were then stained with Ponceau S (Sigma-Aldrich, Gillingham, UK) 
and imaged to check for even loading. Membranes were blocked in 3% dry-milk 
in tris-buffered saline with tween (TBST) for one hour before being incubated in 
primary antibody overnight at 4°C. Membranes were washed in TBST three 
times prior to incubation in appropriate horse radish peroxidase (HRP)-
conjugated secondary antibody at room temperature for one hour. Membranes 
were then washed in TBST three times prior to antibody detection via enhanced 
chemiluminescence HRP substrate detection kit (Millipore, Watford, UK). 
Imaging and band quantification were undertaken using a G:Box Chemi-XR5 
(Syngene, Cambridge, UK). 
 
4.3.8 Antibodies 
All primary antibodies were used at a concentration of 1:1000 in TBST unless 
otherwise stated. Antibodies: acetylated proteins (ab193), ac-MnSODK122 
(ab214675) and OXPHOS cocktail (ab110411) were purchased from abcam; 
AMP-activated protein kinase alpha (AMPKα; 2603), p-AMPKThr172 (2535), p-
ACCSer79 (3661), calmodulin dependent kinase II (CAMKII; 3362), p-
CAMKIIThr268 (12716), cAMP response element binding protein (CREB; 1°: 
1:500; 9197), p-CREBSer133 (1°: 1:500; 9191), glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH; 1:5000; 2118), p38 mitogen activated protein kinase 
(p38 MAPK; 9212), p-p38 MAPKThr180/Tyr182 (4511), poly ADP-ribose polymerase 
1 (PARP1; 1°: 1:500; 9542), tumour protein 53 (p53; 2°: 1:2000; 2527) and ac-
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p53K382 (1°: 1:500 in 3% BSA, 2°: 1:2000; 2570) were purchased from Cell 
Signaling Technology; acetyl CoA carboxylase (ACC; 05-1098), superoxide 
dismutase (MnSOD; 1°: 1:2000; 06-984) and PGC1α (ab3242) and poly-ADP-
ribose (PAR; 1°: 1:500; MABE1031)  were purchased from Merck Millipore. 
Secondary antibodies were used at a concentration of 1:10000 in TBST unless 
otherwise stated. Anti-rabbit (7074) and anti-mouse (7076) antibodies were 
from Cell Signaling Technology. 
 
4.3.9 Real time RT-qPCR 
RNA was extracted from ~20 mg of muscle by homogenising in 1 mL of Tri 
reagent (Sigma Aldrich, Gillingham, UK) using an IKA T10 basic ULTRA-
TURRAX homogeniser (IKA, Oxford, UK). Phase separation was achieved by 
addition of 200 µL of chloroform and centrifugation at 12000 g for 15 minutes. 
The RNA-containing supernatant was removed and mixed with an equal volume 
of 2-propanol. RNA was purified on Reliaprep spin columns (Promega, 
Madison, Wisconsin, USA) using the manufacturers instructions, which includes 
a DNase treatment step. RNA concentrations were determined using the LVis 
function of the FLUOstar Omega microplate reader (BMG Labtech, Aylesbury, 
UK). RNA was diluted to 30 ng·µL-1 and reverse transcribed to cDNA in 20 µL 
volumes using the nanoScript 2 RT kit and oligo(dT) primers (Primerdesign, 
Southampton, UK) as per the manufacturers instructions. RT-qPCR analysis of 
mRNA content was performed in triplicate by using Primerdesign custom 
designed primers (Table 4.1) and commercially available ACTB, B2M and 
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GAPDH, (Primerdesign) and Precision plus qPCR Mastermix with low ROX and 
SYBR (Primerdesign) on a QuantStudio3 Real-Time PCR System (Applied 
Biosystems, Thermo Fisher, UK). The qPCR reaction was run as per the 
manufacturers instructions (Primerdesign) and followed by a melt curve 
(Applied Biosystems) to ascertain specificity. 2-20 ng of cDNA was added to 
each well in a 20 µL reaction volume. qPCR results were analysed using 
Experiment Manager (Thermo Fisher). mRNA expression is expressed relative 
to the expression in the pre-exercise sample during FED for each individual 
using the 2-∆∆CQ method (23) with the geometric mean of Cq values for ACTB, 
B2M and GAPDH used as an internal control (36). Optimal stability of 
housekeeper genes was determined using RefFinder (39). Statistical analyses 
were performed on the ∆∆CQ data. 
 
4.3.1 Blood analyses 
Blood samples were collected into tubes containing ethylenediaminetetraacetic 
acid (EDTA; BD, Oxford, UK) for the collection of plasma. Samples were placed 
immediately upon ice prior to centrifugation at 1600 g at 4°C for 10 minutes 
before collection of plasma from the supernatant. Plasma was frozen at -80°C 
until further analysis. Plasma samples were subsequently analysed on an 
autoanalyser (iLAB650, Instrumentation Laboratory, Bedford, MA, USA) for 
glucose, lactate, non-esterified fatty acid (NEFA) and glycerol (Randox 
Laboratories, County Antrim, UK) using commercially available kits. 
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Table 4.1 qPCR primer sequences 
Gene name Accession 
number 











































Two-way repeated measures ANOVAs assessed effects of time, treatment and 
time*treatment interaction effects for all time-course data. Ryan-Holm-
Bonferroni multiple comparison corrections were applied post-hoc where 
applicable. Differences in means for resting and exercising V O2, V CO2, 
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respiratory exchange ratio (RER), substrate utilisation, heart rate and RPE were 
assessed using repeated-measures t-tests. All statistics were performed using 
the Statistical Package for the Social Sciences (SPSS) version 22.0. Data are 
presented as means with 95% confidence intervals. Statistical significance was 
accepted as p ≤0.05.  
 
4.4 Results 
4.4.1 Substrate utilisation and systemic availability 
Seven days of NR supplementation did not influence resting metabolic rate 
(PLA: 1859 ± 202 vs NR: 1772 ± 211 kcal·d-1; p = 0.486). Furthermore, 
substrate utilisation at rest was similar following supplementation of NR or PLA 
(carbohydrate oxidation: PLA: 0.09 ± 0.04 vs NR: 0.11 ± 0.03 g·min-1; p = 0.446, 
fat oxidation: PLA: 0.10 ± 0.03 vs NR: 0.09 ± 0.02 g·min-1; p = 0.395, RER: 
PLA: 0.79 ± 0.04 vs NR: 0.80 ± 0.03; p = 0.563). Carbohydrate and fat oxidation 
during exercise were also similar between trials (Table 4.2). VO2, VCO2, RER, 
heart rate and RPE did not differ between trials during exercise (Table 4.2). 
 
There was no effect of NR on resting or exercising plasma NEFA, glycerol, 
glucose or lactate (Figure 4.1). Plasma NEFA concentration initially decreased 
during the first 15 minutes of exercise before returning to pre-exercise values 
for the remainder of the exercise bout (main effect of treatment; p = 0.891, time; 
p < 0.001, interaction; p = 0.296). Following exercise (80 minutes) plasma 
NEFA concentration increased and remained elevated above pre-exercise 
values from 120 minutes until the end of the trial (240 minutes). Plasma glycerol 
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concentration increased during exercise and remained elevated above pre-
exercise values for the remainder of the trial (main effect of treatment; p = 
0.106, time; p < 0.001, interaction; p = 0.720). Plasma glucose was marginally, 
although significantly, decreased from pre-exercise values at two hours after 
the cessation of exercise (main effect of treatment; p = 0.175, time; p = 0.010, 
interaction; p = 0.174). Plasma lactate increased during exercise and remained 
elevated for the first 20 minutes of recovery (main effect of treatment; p = 0.192, 
time; p = 0.001, interaction; p = 0.585). 
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Figure 4.1 NR supplementation does not alter plasma NEFA, glycerol, 
glucose or lactate at rest or during exercise 
Time-course for plasma NEFA (A.), glycerol (B.), glucose (C.) and lactate (D.) 
in PLA (black) and NR (grey). b: main effect of time (significantly different to 
pre-exercise; p ≤ 0.05. Data presented as means ± 95% confidence intervals (n 
= 8). 
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4.4.2 Skeletal muscle mitochondrial function and protein content 
Rates of mitochondrial respiration were similar to those previously reported (15, 
16). There were no changes observed in CIL (main effect of treatment; p = 
0.319, time; p = 0.833, interaction; p = 0.588), CIP (main effect of treatment; p = 
0.979, time; p = 0.388, interaction; p = 0.551), CI+IIP (main effect of treatment; p 
= 0.612, time; p = 0.216, interaction; p = 0.993) or CI+IIE (main effect of 
treatment; p = 0.657, time; p = 0.190, interaction; p = 0.621) respiration 
following supplementation of NR or PLA (Figure 4.2A). Furthermore, the content 
of proteins within each of the five electron transport chain complexes were 
unchanged following NR or PLA supplementation (Figure 4.2B; p > 0.05) 
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Figure 4.2 Seven days of NR supplementation does not induce 
mitochondrial biogenesis in skeletal muscle 
A. There were no changes in the mass-specific mitochondrial leak respiration 
through complex I (CIL), coupled respiration through complex I (CIP), coupled 
respiration through complexes I and II (CI+IIP), or maximal electron transport 
chain capacity (CI+IIE) following seven days of NR supplementation (p > 0.05). 
B. Similar content of proteins within the five electron transport chain complexes 
pre- and post-supplementation of PLA (grey) or NR (black) (p > 0.05). C. 
Representative immunoblot images. Data presented as means ± 95% 
confidence intervals (n = 8). 
Nutrition and post-exercise energy-sensing in skeletal muscle 
  178 
4.4.1 Skeletal muscle signalling 
Global acetylation within skeletal muscle was unaffected by NR 
supplementation or exercise (Figure 4.3A; main effect of treatment; p = 0.845, 
time; p = 0.120, interaction; p = 0.106). Furthermore, the acetylation of 
p53Lys382, a SIRT1 deacetylation target (37), and MnSODK122, a SIRT3 
deacetylation target (32), were unchanged throughout the intervention (Figure 
4.3C & D; p53Lys382: main effect of treatment; p = 0.723, time; p = 0.786, 
interaction; p = 0.354, MnSODK122: main effect of treatment; p = 0.324, time; p = 
0.409, interaction; p = 0.332). The protein content of PARP1 was unaffected by 
NR supplementation as post-hoc analyses revealed no significant difference 
despite a significant treatment*time interaction effect (main effect of treatment; p 
= 0.498, time; p = 0.520, interaction; p = 0.040; Figure 4.4A). Auto-PARylation 
of PARP1 was also unchanged by NR or exercise (main effect of treatment; p = 
0.512, time; p = 0.255, interaction; p = 0.115; Figure 4.4B).  
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Figure 4.3 Seven days NR supplementation does not influence sirtuin 
deacetylase activity at rest or following endurance exercise 
A. Global acetylation within skeletal muscle is unaffected by NR 
supplementation or exercise (n = 8; p > 0.05). B. Representative immunoblot 
images of global acetylation and Ponceau S stain. C. Acetylation of p53Lys382, a 
SIRT1 deacetylation site, is unchanged by NR supplementation at rest or 
following endurance exercise (n = 7; p > 0.05). D. Acetylation of MnSODLys122, a 
SIRT3 deacetylation site, is unchanged by NR supplementation at rest or 
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following endurance exercise (n = 8; p > 0.05). -7d: pre-supplementation; Pre: 
pre-exercise (post-supplementation); +0h: immediately post-exercise; +3h: 
three hours post-exercise. All values are presented relative to the group mean 
for all pre-supplementation samples. Data presented as means ± 95% 
confidence intervals. 
 
Exercise increased the phosphorylation of AMPKThr172 (Figure 4.5A, main effect 
of time; p = 0.002) by ~1.6-fold immediately post-exercise (p = 0.031 vs pre-
exercise). There was no effect of treatment (p = 0.216) or a treatment*time 
interaction effect (p = 0.472). Phosphorylation of ACCSer79 (Figure 4.5B) 
increased ~4-fold immediately post-exercise (p < 0.001 vs pre-exercise) and 
remained ~1.4-fold elevated 3-h post-exercise (p = 0.013 vs pre-exercise, main 
effect of time; p < 0.001). CREBSer133 phosphorylation was unaffected by 
exercise or NR (main effect of treatment; p = 0.651, time; p = 0.462, interaction; 
p = 0.810; Figure 4.5C). p38 MAPKThr180/Tyr182 phosphorylation was not 
significantly affected by exercise or NR (Figure 4.5D), as post-hoc analyses 
revealed no significant differences despite a treatment*time interaction effect 
(main effect of treatment; p = 0.124, time; p = 0.942, interaction; p = 0.034). 
CAMKIIThr286 phosphorylation was not altered by exercise or NR (main effect of 
treatment; p = 0.574, time; p = 0.177, interaction; p = 0.236; Figure 4.5E). 
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Figure 4.4 Seven days of NR supplementation does not influence PARP1 
protein content or PARylation 
PARP1 protein content (A.) and auto-PARylation of PARP1 (B.) are unaffected 
by NR supplementation or exercise (p < 0.05). C. Representative immunoblot 
images of PARylation and Ponceau S stain. -7d: pre-supplementation; Pre: pre-
exercise; +0h: immediately post-exercise; +3h: three hours post-exercise. All 
values are presented relative to the group mean for all pre-supplementation 
samples. Data presented as means ± 95% confidence intervals (n = 8). 
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Figure 4.5 Activation of exercise-sensitive signalling pathways following 
NR supplementation and endurance exercise 
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A. Phosphorylation of AMPKThr172 is increased immediately post-exercise in 
each trial. B. Phosphorylation of ACCSer79 is increased immediately post-
exercise and remains elevated three hours post-exercise in each trial. C. 
CREBSer133, D. p38 MAPKThr180/Tyr182 and E. CAMKIIThr286 remain unchanged 
throughout the intervention. F. Representative immunoblot images. -7d: pre-
supplementation; Pre: pre-exercise (post-supplementation); +0h: immediately 
post-exercise; +3h: three hours post-exercise. b: main effect of time 
(significantly different to pre-exercise; p ≤ 0.05). All values are presented 
relative to the group mean for all pre-supplementation samples. Data presented 
as means ± 95% confidence intervals (n = 8). 
 
4.4.1 Metabolic mRNA response 
Seven days of NR supplementation did not alter resting PPARGC1A mRNA 
expression in skeletal muscle (Figure 4.6A). PPARGC1A mRNA increased ~5-
fold three hours post-exercise (p = 0.025 vs pre-exercise, main effect of time; p 
= 0.003). Post-exercise PPARGC1A mRNA expression was similar in PLA and 
NR trials (main effect of treatment; p = 0.257, interaction; p = 0.591). 
 
Expression of pyruvate dehydrogenase kinase 4 (PDK4; Figure 4.6B) increased 
post-exercise (main effect of time; p = 0.001) and was ~10-fold elevated three 
hours post-exercise (p = 0.029 vs pre-exercise). mRNA expression of PDK4 
was similar between PLA and NR trials (main effect of treatment; p = 0.827, 
interaction; p = 0.521). 
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Figure 4.6 Seven days of NR supplementation does not alter resting or 
exercise-induced PPARGC1A or PDK4 mRNA expression 
A. Resting and exercise-induced PPARGC1A mRNA expression is similar 
between NR and PLA trials. B. Resting and exercise-induced PDK4 mRNA 
expression is similar between NR and PLA trials. -7d: pre-supplementation; 
Pre: pre-exercise (post-supplementation); +0h: immediately post-exercise; +3h: 
three hours post-exercise. b: main effect of time (significantly different to pre-
exercise; p ≤ 0.05). All values are presented relative to individual pre-
supplementation values for each trial using the 2-∆∆CQ method. Data presented 
as means ± 95% confidence intervals (n = 8). 
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4.4.2 mRNA expression of enzymes within the NAD+ synthesis 
and salvage pathways 
NR supplementation did not alter the mRNA expression of nicotinamide riboside 
kinase 1 (NMRK1; main effect of treatment; p = 0.432) within skeletal muscle 
(Figure 4.7A). NMRK1 mRNA expression did show a tendency for a main effect 
of time (p = 0.071). There was no treatment*time interaction effect for NMRK1 
mRNA (p = 0.203).  
 
mRNA expression of NAMPT, the rate limiting enzyme in NAD+-salvage (8, 12, 
14), was unaffected by NR supplementation or exercise (Figure 4.7B; main 
effect of treatment; p = 0.303, time; p = 0.305, interaction; p = 0.442). 
Nicotinamide mononucleotide acetyl transferase 1 (NMNAT1) mRNA 
expression was not influenced by NR supplementation (Figure 4.7C), however 
showed a trend to decrease three hours post-exercise (p = 0.065 vs pre-
exercise, main effect of time: p = 0.046). There was no effect of treatment (p = 
0.482) nor a treatment*time interaction effect (p = 0.168). Of note, NMNAT1, the 
nuclear localised isoform, was the only NMNAT isoform that was detectable in 
our human skeletal muscle samples. mRNA expression of the cytosolic and 
mitochondrial isoforms, NMNAT2 and 3 respectively, were indistinguishable 
from the no template controls (data not shown). The Preiss-Handler enzymes 
nicotinic acid phosphoribosyltransferase (NAPRT) and NAD+ synthase 
(NADSYN1) were also undetectable (data not shown). 
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Nicotinamide N-methyltransferase (NNMT) increased in expression three-hours 
post-exercise (Figure 4.7D; p = 0.010 vs pre-exercise, main effect of time: p = 
0.001). However, the post-exercise mRNA expression of NNMT was 
suppressed following NR supplementation (treatment*time interaction: p = 
0.029), such that the exercise-induced NNMT mRNA expression was only 
increased in the PLA trial (PLA 3h post-exercise vs PLA pre-exercise: p = 
0.010), while there was also a trend towards a difference between NR and PLA 
three hours post-exercise (p = 0.116). There was no main effect of treatment (p 
= 0.148). 
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Figure 4.7 mRNA expression of enzymes in the NAD+ synthesis and 
salvage pathways within skeletal muscle following NR supplementation 
and endurance exercise 
The mRNA expression of A. NMRK1 and B. NAMPT were unaffected by NR 
supplementation or endurance exercise. C. NMNAT1 mRNA expression 
displayed a tendency to decrease three hours post-exercise (p = 0.065). D. The 
mRNA expression of NNMT increased three hours post-exercise in PLA but this 
was impaired following NR supplementation. -7d: pre-supplementation; Pre: 
pre-exercise (post-supplementation); +0h: immediately post-exercise; +3h: 
three hours post-exercise. c: interaction effect (different to pre-exercise within 
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treatment; p ≤ 0.05). All values are presented relative to individual pre-
supplementation values for the each trial using the 2-∆∆CQ method. Data 
presented as means ± 95% confidence intervals (n = 8). 
 
4.5 Discussion 
Contrary to our hypothesis the activity of the NAD+-dependent deacetylases 
SIRT1 and SIRT3 and the mRNA expression of PPARGC1A within skeletal 
muscle were unaffected by NR supplementation. Furthermore, seven days of 
NR supplementation at 1000 mg·d-1 did not alter metabolism at the whole-body 
level or within skeletal muscle. Finally, and somewhat surprisingly, NR impaired 
the endurance exercise-induced increases in skeletal muscle expression of 
NNMT mRNA, an enzyme putatively involved in regulating whole-body fatty 
acid metabolism (31). 
 
Supplementation of 1000 mg·d-1 of NR for seven days was insufficient to alter 
sirtuin activity in human skeletal muscle at rest or following endurance exercise. 
Acetylation of p53Lys382, a SIRT1 deacetylation target (37), and MnSODLys122, a 
SIRT3 deacetylation target (32), as well as global acetylation were unchanged 
throughout the intervention. Furthermore, the basal and exercise-induced 
expression of PPARGC1A mRNA was similar between NR and PLA trials, 
indicative of similar PGC1α activity (17). In rodents supplemented with NR for 
periods of 4-16 weeks skeletal muscle SIRT1 and SIRT3 are activated and 
mitochondrial biogenesis is induced (5, 6, 19, 29). However, on the whole, it 
does appear that sirtuin activity is more tightly regulated in human rather than 
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rodent skeletal muscle. For example, endurance exercise induces p53 
deacetylation in mice (27) but not in humans (Chapter 3). Thus, given the lower 
metabolic rate and likely slower NAD+-turnover in human compared to rodent 
skeletal muscle, the NAD+-metabolome and consequent SIRT signalling may be 
less sensitive to NR supplementation in human skeletal muscle. Furthermore, 
PARP1 protein content and activity, as assessed by PARP1 auto-PARylation 
(33) was not significantly induced by exercise or NR supplementation in the 
current study. This is in partial contrast to data from chapter 3, whereby PARP1 
protein content was decreased post-exercise, suggesting that exercise intensity 
(i.e. 70% Wmax in chapter 3 vs 60% Wmax in the current chapter) is an important 
modulator of PARP1 protein content. However, this does support rodent data 
showing that NR supplementation does not alter basal PARylation within 
skeletal muscle (5, 29). 
 
NR supplementation for one week did not alter circulating substrate availability 
or whole-body substrate utilisation either at rest or during 60% Wmax cycling in 
healthy recreationally active males. This is in accordance with recent reports 
where NR supplementation of 1000 mg·d-1 for six weeks and 2000 mg·d-1 for 12 
weeks had no effect on resting energy expenditure, substrate utilisation or 
fasting concentrations of glucose or NEFA (11, 25). Furthermore, six weeks of 
NR supplementation does not alter RER during an incremental exercise test in 
elderly males (25). However, these data are in contrast to rodent studies, which 
have demonstrated that NR supplementation can increase metabolic flexibility 
(30) and fat oxidation during the inactive phase (5), which occurs alongside 
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induced mitochondrial biogenesis (5). Changes in substrate utilisation with NR 
supplementation may, therefore, be a physiological outcome of mitochondrial 
biogenesis. Indeed, in the current study no changes in skeletal muscle 
mitochondrial respiration or content of electron transport chain proteins were 
apparent, which perhaps is unsurprising given the relatively short 
supplementation period. Nonetheless, just two weeks of 750 mg·d-1 
supplementation of acipimox, a nicotinic acid (NA)-derivative and thus an NAD+ 
precursor, increases skeletal muscle mitochondrial respiratory capacity in type II 
diabetics (35). However, whether the mitochondrial biogenic effects of acipimox 
in this population are derived from alterations in skeletal muscle NAD+-
metabolism or the confounding effects of NA-induced alterations in whole-body 
NEFA metabolism remains unclear (35). Studies employing longer duration NR 
supplementation in basal and exercising conditions that investigate the effect of 
NR supplementation on mitochondrial biogenesis in humans are warranted. 
 
Our data indicates that exercise and NR alter the NAD+-consumption/salvage 
machinery within skeletal muscle. The mRNA expression of NNMT, a 
methyltransferase of nicotinamide (NAM) that produces methylated NAM 
(MeNAM) and prevents NAD+-salvage (2), is increased following endurance 
exercise although this was impaired by NR supplementation. Previous studies 
have also shown an increase in skeletal muscle NNMT mRNA and/or protein 
expression following endurance exercise training in rats (21) and four days of 
energy restriction in humans (31). Ström et al (31) went on to demonstrate 
elevated skeletal muscle NNMT mRNA expression coincided with an increase 
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in circulating MeNAM. In addition, plasma MeNAM concentrations are increased 
following a single bout of endurance exercise in mice, an effect that could only 
be partially explained by increased NNMT activity in the liver (7). MeNAM can 
be secreted from human primary myotubes and can induce lipolysis in rat 
primary adipocytes (31). However, despite elevations in circulating MeNAM 
during NR supplementation in humans (34), whole-body fatty acid availability at 
rest, during exercise and during the post-exercise recovery period are 
unaffected by NR supplementation. The reduction in exercise-induced skeletal 
muscle NNMT mRNA expression following NR supplementation is a particularly 
surprising finding given elevated plasma MeNAM concentrations during NR 
supplementation (34). However, as the liver is the major NR-consuming organ 
(22) and hepatic NNMT activity is high (7) it is likely that the source of additional 
NR-derived circulating MeNAM is the liver, and it is possible that a negative 
feedback loop could be preventing additional activation of NNMT in skeletal 
muscle. The chronic effects of NR on impairing exercise-induced NNMT mRNA 
expression on skeletal muscle NNMT content and activity, and whole-body and 
skeletal muscle fatty acid metabolism, warrant further investigation. 
 
A current limitation of this study is that the NAD+-metabolome in skeletal muscle 
and blood was not analysed. A lack of alteration of metabolism, skeletal muscle 
mitochondrial biogenesis or sirtuin activity in the current study raises the 
question of whether this supplementation protocol sufficiently altered skeletal 
muscle NAD+ concentrations, at least prior to and/or during exercise. Seven 
days of 1000 mg·d-1 NR supplementation was chosen as this dose and duration 
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was deemed safe and is sufficient to alter the NAD+-metabolome in plasma and 
PBMCs of human participants (34). Furthermore, one week of NR 
supplementation increases skeletal muscle NAD+ concentration in mice (5). 
Nonetheless, the effect and time course of NR supplementation on the skeletal 
muscle NAD+-metabolome in humans remains unstudied and a skeletal muscle 
bioavailability study is warranted. Despite this, a suppression of NNMT mRNA 
expression three hours post-exercise in the NR trial does indicate that, at least 
at this time point, the skeletal muscle NAD+-metabolome may be different 
between NR and PLA trials. Analysis of the NAD+-metabolome in skeletal 
muscle and plasma would be particularly informative moving forward. 
 
Overall, 1000 mg·d-1 of NR supplementation for seven days does not alter 
mitochondrial biogenic signalling, including sirtuin activity and PPARGC1A 
mRNA expression, in resting or exercised human skeletal muscle. Furthermore, 
one week of NR supplementation did not influence substrate metabolism at rest 
or during 60% Wmax cycling. Despite this, NR supplementation did reduce the 
exercise-induced expression of NNMT mRNA in skeletal muscle, which plays a 
putative role in whole-body fatty acid metabolism. 
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5.1 Introduction 
Repeated activation of endurance exercise-sensitive signalling pathways 
induces metabolic adaptations, including mitochondrial biogenesis, within 
skeletal muscle (23). Ultimately, these adaptations contribute to the 
improvement and/or maintenance of whole-body health. Despite this, the 
optimal activation of these pathways remains incompletely understood. 
Therefore, the overarching aim of this thesis was to expand upon our 
understanding of the regulation of post-exercise signalling pathways within 
skeletal muscle, with specific focus on the activation of energy-sensitive 
signalling pathways. Furthermore, how fasting and nicotinamide riboside (NR), 
a nicotinamide adenine dinucleotide (NAD+) donor influence metabolism was of 
particular interest. 
 
To address these questions this thesis utilised a translational approach 
incorporating a rodent model to examine the skeletal muscle-specific role of 
tumour protein p53 (p53), a putative mitochondrial biogenic regulator, followed 
by two human physiology studies investigating the influence of nutrition on 
exercise-sensitive signalling pathways. This chapter will summarise, synthesise 
and further contextualise the data contained within this thesis. 
 
5.2 Role of p53 in skeletal muscle mitochondrial biogenesis 
P53 is purported to be an important regulator of mitochondrial biogenesis within 
skeletal muscle. Whole-body knockout (KO) of p53 impairs mitochondrial 
content and function in skeletal muscle (22, 26, 27). However, whether this 
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resulted from a loss of p53 in skeletal muscle per se remained unclear. Here we 
demonstrated that mice containing a muscle-specific knockout (mKO) of p53 did 
not exhibit mitochondrial defects (Chapter 2). Thus we concluded that the 
mitochondrial dysfunction in whole-body p53 KO mice was not due to a loss of 
p53 in developed skeletal muscle fibres. Nonetheless, this does not preclude 
p53 a role in mitochondrial biogenesis, as compensatory mechanisms may be 
at play, or within the post-exercise adaptive response. Particularly, p53 
undergoes post-translational modifications in response to endurance exercise 
(5, 6, 18, 24, 26) and fasting (15), indicative of a functional regulation of p53 by 
energy stress and exercise. Thus we continued to study p53, namely its 
acetylation status, in the context of endurance exercise. In contrast to exercise 
in mice (24) and prolonged (48 hour) fasting in humans (15), p53Lys382 
acetylation was unresponsive to an ~12 hour fast, one-week of NR 
supplementation or exercise performed in fed, fasted or NR supplemented 
states. Therefore, it appears that greater metabolic stress, as apparent in near-
exhaustive exercise in mice or prolonged fasting in humans, is required to alter 
p53 acetylation in human skeletal muscle. 
 
5.3 Manipulating nutrition to influence metabolism  
During moderate-intensity exercise (50-75% VO2peak), fasting augments fatty 
acid availability and fat oxidation (1, 2, 9-11, 13, 16, 32). However, at higher 
exercise intensities, substrate utilisation is similar between fed and fasted 
exercise, despite differential systemic fatty acid availability (Chapter 3)(32). NR 
also has the potential to augment fatty acid metabolism (7, 28), although a 
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recent report suggests this does not occur in resting humans (14). Our data 
corroborates Dollerup et al (14), showing that NR supplementation (albeit for a 
shorter duration) does not alter substrate utilisation or fatty acid availability at 
rest and advances this published work to demonstrate that this is also the case 
during steady-state endurance exercise. Furthermore, skeletal muscle 
mitochondrial respiration is unaffected by one week of 1000 mg·d-1 NR 
supplementation (Chapter 4). 
 
5.4 Manipulating nutrition to influence skeletal muscle signalling  
Increased activation of AMP-activated protein kinase (AMPK) and fatty acid 
oxidative mRNA transcripts in response to fasted exercise has been previously 
reported (2, 10, 11, 13, 19). Here we show that during moderate- to high steady 
state exercise (70% Wmax) fasting and fasted-exercise augment AMPKThr172 
phosphorylation and pyruvate dehydrogenase kinase 4 (PDK4) mRNA 
expression. Furthermore, we provide support for previous studies that suggest 
that fasting elevates cAMP response-element binding protein (CREB)Ser133 
phosphorylation (33). Despite elevated AMPKThr172 and CREBSer133 
phosphorylation, the downstream exercise-induced activation of peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A) mRNA 
expression was unaffected by fasting. Previous literature has also 
demonstrated similar exercise-induced activation of PPARGC1A mRNA in fed 
and fasted states (10, 11). Taken together, these data suggest that fasting and 
fasted exercise can readily influence the fatty acid metabolic machinery, 
however greater energy stress is required to alter the regulation of the 
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mitochondrial biogenic regulator peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha (PGC1α). Indeed, a similar effect is apparent with 
chronic exercise training. Fasted exercise training in males augments training-
induced increases in fatty acid metabolic protein content, 3-hydroxyacyl-CoA 
dehydrogenase (β-HAD) enzyme activity, maximal fatty acid oxidation rate and 
intramyocellular lipid breakdown during fasted exercise (12, 31). However, the 
effect of fasting on surrogate markers of exercise-induced mitochondrial 
biogenesis is more inconsistent (12, 29, 31). 
 
Sirtuin 1 (SIRT1) activity, as measured by the acetylation of p53Lys382, was 
unaltered by 12 hours of fasting and exercise performed in the fasted, fed and 
NR supplemented states. Elevated SIRT1 mRNA expression alongside p53 
deacetylation has been reported following 48 hours of fasting in human skeletal 
muscle (15), whilst exercise (24) and NR supplementation induces SIRT1-
related deacetylation in rodents (7, 8, 20). SIRT1 deacetylates and activates 
PGC1α (17). However, an induction of PPARGC1A mRNA in spite of a lack of 
exercise-induced activation of SIRT1 in chapters 3 and 4 provides further 
evidence for the potential redundancy of SIRT1 in exercise-induced PGC1α 
activation (24). Furthermore, the concomitant lack of alteration in SIRT1 and 
SIRT3 activity and global acetylation across the nutritional and exercise 
interventions within Chapters 3 and 4 suggests that a substantial degree of 
metabolic stress is required to alter acetylation and sirtuin signalling in human 
skeletal muscle. In addition, for the first time in exercised human skeletal 
muscle, we analysed the activity of PARP1, which competes with SIRTs for 
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NAD+ (3, 21, 25). PARP1 protein content decreased following cycling at 70% 
Wmax but not 60% Wmax, indicating that exercise intensity, and the associated 
cellular stress, is an important modulator of PARP1 protein content. However, 
PARylation, and therefore PARP activity, was unaffected by exercising, fasting 
or NR supplementation. 
 
5.5 Recommendations for practice 
Fasted exercise increases fatty acid availability, fat oxidation (at moderate 
exercise intensities) and mRNA transcripts involved in fatty acid utilisation within 
skeletal muscle. If the individual aim is to increase the capacity for fat oxidation 
then fasted exercise training represents a good strategy (4). Conversely, 
training in the fed-state promotes carbohydrate oxidation (12) and may be 
beneficial in maintaining glucose control (16). Thus there appears to be benefits 
of both fed and fasted exercise, with the choice of the nutritional strategy 
dependent upon the desired outcome. It is also noteworthy to highlight our 
observation of a statistical trend for an elevated rating of perceived exertion 
(RPE) during fasted exercise and anecdotally participants certainly suggested 
that they found the fasted exercise harder. Ultimately, any exercise is better 
than no exercise so in many cases the recommendation for most individuals 
should be to exercise in a way that they enjoy or at least can best tolerate. 
 
From the available evidence and the data presented herein, we conclude that it 
is premature to recommend NR supplementation to improve metabolic health or 
augment endurance exercise adaptations in humans, despite promising 
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evidence from rodent models. Optimal NR supplementation strategies to 
increase NAD+ concentration in skeletal muscle (or other tissues) are still 
unknown. Additionally, the apparent effect of impairing nicotinamide N-
methyltransferase (NNMT) mRNA expression, which may be involved in 




As with all research, the studies contained within this thesis should be 
considered within their context and as such extrapolation should be considered 
with care. For example, analysis of mitochondrial content and enzyme activity in 
p53 mKO mice (Chapter 2) was undertaken in young healthy mice and does not 
rule out the potential for an important role of skeletal muscle p53 for 
mitochondrial function with ageing, other deleterious conditions or during 
endurance exercise training. The human physiology studies within chapters 3 
and 4 are limited by sample size due to the onerous nature of performing such 
studies. Furthermore, these studies were only performed in young healthy 
males, therefore age and/or sex-based differences cannot be excluded. 
Analyses in these studies were also restricted by tissue quantities and feasibility 
of experimental techniques. Indeed, the semi-quantitative nature of the 
immunoblotting may limit the sensitivity of these analyses. A proteomic 
methodology would likely provide greater sensitivity, whilst this ‘untargeted’ 
approach would also provide a broader insight. Finally, the human physiology 
studies are acute in nature, with limited time points, and as such provide only a 
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snapshot in time. Long-duration training studies are ultimately required to 
understand the true adaptive nature of these interventions. 
 
5.7 Future research 
Future studies should examine the muscle-specific role of p53 during additional 
physiological stressors such as endurance exercise training and ageing. In 
addition, the role and regulation of post-translational modifications of p53 and 
how these relate to the function of p53 within skeletal muscle still need to be 
clearly defined. The effects of fasting, exercise and NR on the NAD+-
metabolome is particularly intriguing, especially in the context of the interaction 
between exercise and NR in the regulation of NNMT and the metabolic role of 
methylated nicotinamide (MeNAM). Further analysis of samples collected during 
these PhD studies will hopefully add another piece to this complex puzzle. NR 
supplementation in humans remains a promising strategy but research 
investigating the optimal supplementation strategy in terms of dose, frequency 
and duration of supplementation is required. It is also to be determined whether 
NR supplementation can augment endurance-training adaptations. Finally, it 
should be examined whether similar or divergent effects of these studies are 
apparent in different populations (e.g. females or the elderly). 
 
5.8 Conclusions 
Throughout this thesis we have investigated the regulation of exercise-sensitive 
signalling pathways. In particular, we demonstrate that skeletal muscle p53 is 
not required for developing or maintaining mitochondrial function in young 
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healthy mice; that fasting and fasted exercise induces the phosphorylation of 
CREBSer133 and AMPKThr172 while augmenting the mRNA expression of PDK4 
but not PPARGC1A; and one week of NR supplementation at 1000 mg·d-1 does 
not alter skeletal muscle mitochondrial respiration and whole-body substrate 
utilisation at rest or during endurance exercise, while SIRT1 and SIRT3 activity 
and PPARGC1A mRNA expression at rest and following endurance-exercise 
are also unaffected by NR supplementation. An unexpected finding of this 
thesis is that supplementation of NR may suppress post-exercise induction of 
skeletal muscle NNMT mRNA expression, an enzyme putatively involved in 
regulating whole-body fatty acid metabolism (30). Overall, this thesis contributes 
novel data to the understanding of metabolism and skeletal muscle signalling 
following endurance exercise and how nutrition and endurance exercise could 
be integrated to optimise specific adaptations. 
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6 APPENDICES 
Figure 6.1 Abundance of selected proteins are similar in the quadriceps 
muscle of p53 mKO and WT mice 
WT (black circles) and p53 mKO (grey squares) mice display similar content of 
A. mitochondrial proteins and proteins involved in B. mitochondrial morphology, 
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biogenic signalling and transcription within quadriceps muscle (p > 0.05; n = 6 
per group). 
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Figure 6.2 Abundance of selected proteins are similar in the triceps 
muscle of p53 mKO and WT mice 
WT (black circles) and p53 mKO (grey squares) mice display similar content of 
A. mitochondrial proteins and proteins involved in B. mitochondrial morphology, 
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biogenic signalling and transcription within quadriceps muscle (p > 0.05; n = 5-6 
per group). 
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Figure 6.3 Similar CS and β-HAD activity is apparent between p53 mKO 
and WT mice in both gastrocnemius and quadriceps muscle 
WT (black circles) and p53 mKO (grey squares) mice display similar activity of 
CS in A. gastrocnemius and B. quadriceps muscle (p > 0.05; n = 6 per group). 
Similar activities of β-HAD are apparent in C. gastrocnemius and D. quadriceps 
muscle (p > 0.05; n = 6 per group). 
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